Studies on the characterization and regulation of two major nuclear pore complex proteins Nup98 and Nup96 by Enninga, Jost
Studies on the Characterization and Regulation of two
major Nuclear Pore Complex Proteins Nup98 and Nup96
Vom Fachbereich Chemie der Universität Hannover
zur Erlangung des Grades
Doktor der Naturwissenschaften
Dr. rer. nat.
genehmigte Dissertation
von
Jost Enninga
geboren am 13. Juli 1976 in Goslar
2003/2004
Referent: Prof. Dr. Walter Müller
Korreferent(en): Prof. Dr. Beatriz Fontoura
Prof. Dr. Karl Bauer
Tag der Disputation: 31. Oktober 2003
Wer die Menschen einst fliegen lehrt,
der hat alle Grenzsteine verrückt;
alle Grenzsteine selber werden ihm in die Luft fliegen,
die Erde wird er neu taufen
- als "die Leichte."
Acknowledgments:
I would like to especially thank Beatriz Fontoura for innumerable, not only Cell Biology
related things. That was a lot of fun in New York and Miami! I am very sorry that I did
not have any sense of German order or organization. In retrospect, it was good that way,
perhaps.
I am very grateful to Günter Blobel, for his trust, enthusiasm and commitment letting me
pursue this PhD project in his laboratory. All the long discussions helped me a lot to
think very clearly (at least) in scientific terms. I am very thankful for the opportunity to
work independently on my research projects and for all the insightful suggestions.
Lots of thanks to all other Blobelites! In particular, I would like to mention Hualin
Zhong, Joe Glavy and Evette Ellison from the sunshine bay- you know why. Egbert
Hoiczyk for taking the time to chat at the weirdest hours during the day (and night), Chia
Wu for being a super bay-mate, Thomas Schwartz for his great enthusiasm in the lab and
for some of the most interesting discussions, Samuel Dales for lots of helpful comments
and insights into electron microscopy, Stepanka Melcakova for creating a good
atmosphere in the lab and out of the lab, Thomas Böhmer for being a great lab- and
room-mate, and Elias Coutavas for lots of interesting scientific discussions and for
showing me how beneficial and easy to use Apple computers are.
There were many more scientific people important for this project in New York: Here, I
just want to acknowledge Allison North from the microscopy facility at the Rockefeller
University, Helen Shio for helping with the EM, and David Levy from the Department of
Pathology at NYU.
In Miami, I wish to thank Helene Valentine and Agata Levay in particular, not only for
helping me with several things in the lab. You were responsible that I had a great time in
Florida. I would also like to thank everybody else in Beatriz’s laboratory.
Then, there are several people who have been of utmost importance for this thesis outside
the laboratory: Especially, I would like to thank Kristine Schauer and Arun Prakash.
In Hannover, I would like to thank Walter Müller for his support over all these years. I
appreciate that you were able to find some moments any time I came to your office. I am
looking forward to seeing you during further visits. In addition, I would like to say thank
you to Karl Bauer for participating at my thesis defense and for all his supportive words.
Finally, I would also like to acknowledge Michael Kracht for showing me how exciting
research can be.
Throughout this thesis, I was very happy to have my parents, who were always there
when I needed help, thank you very much.
Jost Enninga- Nup98 and Nup96                                                                                       1
1. Content
1. CONTENT 1
2. ZUSAMMENFASSUNG 3
3. ABSTRACT 5
4. ABBREVIATIONS 6
5. INTRODUCTION 8
5.1. General Introduction 8
5.2. The Nuclear Pore Complex- Its Structure and its Components 8
5.3. Methods to study the Nuclear Pore Complex 13
5.4. Subcomplexes of the Nuclear Pore Complex 15
5.5. The Nuclear Pore Complex throughout the Cell Cycle 17
5.6. The Nucleoporins Nup98 and Nup96 17
5.7. Role of Nucleoporins in Disease: Leukemia and Viral Infection paradigms 20
6. OBJECTIVE OF THIS THESIS 23
7. MATERIALS AND METHODS 25
7.1. Molecular Biology 25
7.1.1. Plasmid Construction 25
7.1.2. Northern Blotting 26
7.1.3. Semiquantitative RT-PCR 27
7.1.4. Yeast Two Hybrid Assay 28
7.2. Biochemistry 29
7.2.1. Preparation of Nuclear Envelopes from Rat Liver 29
7.2.2. Protein Expression, In-Vitro-Binding and Immuno-precipitation 30
7.2.3. Immunoblot Analysis 31
7.2.4. Antibody Production and Purification 32
7.2.5. Reporter Gene Assays 33
7.3. Cell Biology 34
7.3.1. Cell Culture, Transfection, and Cytokine Treatment 34
7.3.2. In Situ Hybridization of poly(A) RNAs 35
7.3.3. Immunofluorescence and Confocal Microscopy 36
7.3.4. Fluorescence Recovery after Photobleaching (FRAP) and Fluorescence Loss in
Photobleaching (FLIP) 36
Jost Enninga- Nup98 and Nup96                                                                                       2
7.3.5. Immuno Electron Microscopy of Nuclear Envelopes 37
8. RESULTS 39
8.1. Overview 39
8.2. Part A: The Expression and Localization of Nup98 and Nup96 39
8.2.1. Differential Expression of the Nup98/Nup96 gene in Human Tissues 39
8.2.2. The intracellular Localization of Nup98 41
8.2.3. The intracellular Localization of Nup96 and its Isoforms 43
8.3. Part B: A possible Role of Nucleoporins in an antiviral Response 46
8.3.1. Nup98 and Nup96 are up-regulated by interferons 47
8.3.2. STAT1 regulates Nup98 and Nup96 Expression 48
8.3.3. The Amounts of Nup98 and Nup96, but not their Localization, are regulated by IFNg50
8.3.4. IFNg Treatment or increased Amounts of Nup98 and Nup96 reverse an mRNA
Export Blockage caused by the VSV M Protein 51
8.4. Part C: Identification of new binding partners of Nup96 54
8.4.1. Specific interaction of Sec13 with an amino-terminal Region of Nup96 54
8.4.2. In Interphase, Sec13 and Nup96 are localized at both Sides of the NPC in addition to
other intracellular Sites 57
8.4.3. In Mitosis, Nup98 and Sec13 are diffused throughtout the Cell whereas a significant
Fraction of Nup96 co-localizes with the Spindle Apparatus 59
8.4.4. Targeting of Sec13 to different Compartments in the Cell 61
8.4.5. Sec13 shuttles between the Nucleus and the Cytoplasm and stably associates with
NPCs 63
9. DISCUSSION 68
9. 1. Overview 68
9.2. The Localization of Nup98 and Nup96 at the Nuclear Pore Complex 68
9.3. Nucleoporin Localization and their hypothetical Functions during Mitosis 69
9.4. The Regulation of Nup98 and Nup96 by Interferons 70
9.5. Potential Roles of Nup Regulation by Interferons in antiviral Responses 72
9.6. Searching for Nup96 Interactors: Sec13- a Protein which is localized at the NPC and
shuttles between the Nucleus and the Cytoplasm 73
9.7. Two separate Pools of Sec13 reveal structural and functional Differences 74
9.8. Conclusion 75
10. REFERENCES: 77
Jost Enninga- Nup98 and Nup96                                                                                       3
2. Zusammenfassung
Moleküle werden in eukaryontischen Zellen zwischen dem Zytoplasma und
dem Nukleoplasma durch Kernporen transportiert.  Diese genau regulierten
Strukturen kontrollieren den Influx und Efflux einer Vielzahl von Molekülen,
wie Transkriptionsfaktoren, RNS, Kinasen und viralen Partikeln. Kernporen
bestehen aus 30 bis 40 konservierten Proteinen, die zusammen als
Nukleoporine bezeichnet werden. In dieser Arbeit wurden die beiden
wichtigen Nukleoporine Nup98 und Nup96 charakterisiert, welche von einem
Gen kodiert sind. Nach Transkription und Translation des Nup98-Nup96 Gens
wird das Vorläufermolekül durch Autoproteolyse gespalten. Das N-terminale
Nup98 ist ein Schlüsselmolekül für die Kontrolle des Kerntransports von
Proteinen und Nukleinsäuren. Das C-terminale Nup96 ist Bestandteil der als
Nup107-160 Komplex bezeichneten Unterstruktur der Kernpore, es ist aber
nichts über seine Funktion bekannt. DNS Hybridisierungen zeigten, daß das
Nup98-Nup96 Gen in allen wichtigen Organen in Mammalia exprimiert wird.
Durch indirekte Immunofluoreszenz mit kultivierten Zellen und
Immunoelektronenmikroskopie mit aus Rattenlebern isolierten
Kernmembranen wurden Nup98 und Nup96 an beiden Seiten der Kernpore
und weiteren intranukleären Orten lokalisiert. Es ist bekannt, daß die Virulenz
des vesikuloviralen M-Proteins von seiner Bindung mit Nup98 herrührt,
welche den Transport von mRNA aus dem Nukleus verhindert. Wir fanden,
daß sowohl Nup98 als auch Nup96 durch Interferone reguliert werden.
Experimente in STAT1 Deletionszellinien deuteten auf eine entscheidende
Rolle dieses Moleküls in der durch Interferon vermittelten Nup98-Nup96
Genregulation. M-Protein vermittelte Inhibierung des nukleären Exports von
mRNS konnte durch Induktion von Zellen mit Interferon g oder durch
Transfektion komplementärer Nup98-Nup96 kodierender DNS rückgängig
gemacht werden. Um Nup96 Bindungspartner zu identifizieren und zu
charakterisieren, wurde hier gezeigt, daß sein N-Terminus mit der N-
terminalen Propellerstruktur von Sec13 in einem Hefe-Hybrid-System und in
biochemischen Bindungsstudien interagierte. Sec13 ist ein Konstituent des
endoplasmatischen Retikulums, wo es für den Zusammenbau von CopII-
Komplexen wichtig ist, und der Kernpore, wo seine Funktion unbekannt ist.
Während der Interphase konnten wir Sec13 auf beiden Seiten der Kernpore
lokalisieren. Jedoch wurde Sec13 während der Mitose dispers in der Zelle
gefunden, wohingegen Nup96 mit dem Spindelapparat kolokalisierte.
Photobleichungsexperimente zeigten Migration von Sec13 zwischen
intrazellulären Orten und dem endoplasmatischen Retikulum, wohingegen
eine Fraktion von Sec13 stabil mit der Kernpore interagierte. Durch
Kotransfektion von Sec13 und der Sec13-Bindungsstelle von Nup96 wurde
ihre wechselseitige Bindung in vivo demonstriert. Mittels Deletionsmutanten
wurde gezeigt, daß Sec13 aktiv transportiert wird und eine nukleäre
Lokalisationssequenz enthält. Zusammengenommen zeigen diese Studien, wie
genau reguliert und dynamisch Nukleoporine sind, und wie sie die Kernpore
mit anderen Zellkompartimenten verbinden. Ferner wurde demonstriert, daß
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Nukleoporine von herausragender Bedeutung in genau regulierten zellulären
Prozessen wie der antiviralen Antwort sind.
Schlüsselwörter:
Kernporenkomplex, Nukleoporin, Gen Regulation
Keywords:
Nuclear Pore Complex, Nucleoporin, Gene Regulation
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3. Abstract
The transport of molecules between the nucleus and the cytoplasm of
eukaryotic cells occurs through nuclear pore complexes (NPC). These highly
regulated cellular structures control nuclear entry and exit of molecules such
as transcription factors, RNAs, kinases and viral particles. NPCs consist of
thirty to forty conserved proteins, which are collectively called nucleoporins
(Nups). Here, we characterize two major Nups termed Nup98 and Nup96,
which are encoded by the same gene. After transcription and translation of the
Nup98-Nup96 gene, the precursor is cleaved by an autoproteolytic pathway.
The N terminal Nup98 is a key controller of nuclear entry and exit of proteins
and nucleic acids. The C terminal Nup96 is a component of a NPC
subcomplex termed Nup107-160 complex, however, nothing is known about
its function. Northern blot analysis revealed that the Nup98-Nup96 gene is
expressed in various amounts in mammals in all major tissues. Performing
indirect immunofluorescence on cultured cells and immuno electron
microscopy on isolated nuclear envelopes from rat liver, Nup98 and Nup96
were localized at both sides of the NPC and at intranuclear sites. It has been
shown that Nup98 is the target of the vesicular virus stomatitis (VSV) matrix
(M) protein-mediated inhibition of messenger RNA (mRNA) export. We
found that Nup98 and Nup96 were up-regulated by interferons (IFN).
Experiments with STAT1 knockout cell lines indicated the crucial role of the
STAT1 molecule in regulating interferon dependent Nup98-Nup96 gene
expression. M protein-mediated inhibition of mRNA nuclear export was
reversed when cells were treated with IFNg  or transfected with a
complementary DNA encoding Nup98 and Nup96. To identify and
characterize Nup96 and its binding partners, we found that its N-terminus
binds to the WD (Trp-Asp) repeat region of Sec13 in a yeast two-hybrid assay
and in biochemical binding assays. Sec13 is a constituent of the endoplasmic
reticulum (ER) and the NPC. At the ER, Sec13 is involved in the biogenesis
of COPII-coated vesicles whereas at the NPC its function is unknown. During
interphase, Sec13 was found on both sides of the NPC. However in mitosis,
Sec13 was found dispersed throughout the cell whereas a pool of Nup96 co-
localized with the spindle apparatus. Photobleaching experiments showed that
Sec13 shuttles between intranuclear sites and the cytoplasm, and a fraction of
Sec13 is stably associated with NPCs. Co-transfection of Sec13 and the Sec13
binding site of Nup96 decreased the mobile pool of Sec13 demonstrating the
interaction of Sec13 and Nup96 in vivo. Targeting studies showed that Sec13
is actively transported into the nucleus and contains a nuclear localization
signal. Taken together, these findings suggest that nucleoporins are highly
regulated and dynamic molecules bridging the nuclear envelope with other
cellular compartments. Furthermore, the regulation of Nups plays a pivotal
role in highly controlled cellular processes such as antiviral responses.
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4. Abbreviations
This list does not include units and abbreviations that are commonly used in
biochemistry and cell biology textbooks (e.g., Sambrook et al., 1989), such as
ml, DNA, mRNA, ATP, etc.
AML Acute Myeloid Leukemia
ATCC American Tissue Culture Collection
bgal b Galactosidase
BSA Bovine Serum Albumin
CBP CREB Binding Protein
CMV Cytomegolovirus
Crm1 Chromosome Region Maintenance 1
DMEM Dulbecco’s Modified Eagle Medium
ds double stranded
DTT 1,4-Dithio-DL-Threitrol
EDTA Ethylendiaminetetraacetic Acid
EM Electron Microscopy
ER Endoplasmic Reticulum
FEISEM Field Emission In-Lens Scanning Electron Microscopy
FITC Fluorescein Isothiocyanate
FLIP Fluorescence Loss In Photobleaching
FRAP Fluorescence Recovery After Photobleaching
GAS Interferon g Activated Sequence
GFP Green Fluorescent Protein
Gle2p GLFG Lethal Protein 2
GLEBS Gle2p Binding Protein
GST Glutathione-S-Transferase
HeLa Helen Lang
HEPES N-(2-Hydroxyethyl)Piperazine-N'-2-Ethanesulfonic
Acid
HIV Human Immunodeficiency Virus
HoxA9 Homeobox Containing Gene A9
HPO Horseradish Peroxidase
IFN Interferon
IgG Immunglobulin G
IPTG Isopropyl-1-thio-b-D-Galactose
ISRE Interferon Signaling Responsive Element
JAK Janus Kinase
Kap Karyopherin
MAPK Mitogen Activated Protein Kinase
MDS Myelodysplastic Syndrome
MMLV Moloney Murine Leukemia Virus
M protein Matrix Protein
MTN Multiple Tissue Northern Blot
NE Nuclear Envelope
NES Nuclear Export Sequence
NLS Nuclear Localization Sequence
NP-40 Nonylphenyl-(Polyethylene)-Glycol 40
NPC Nuclear Pore Complex
Nup Nucleoporin
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PAGE Polyacrylamide Gelelectrophoresis
PBS Phosphate Buffered Saline
PCR Polymerase Chain Reaction
PK Pyruvate Kinase
PML Promyelocytic Leukemia
PMSF Phenylmethylsulfonyl Fluoride
POM Pore Membrane Protein
PVDF Polyvinylidene Fluoride
Rae1 Ribonucleic Acid Export Factor 1
Ran Ras Like Nuclear
RanGAP RanGTPase Activating Protein
RanGEF RanGTPase Exchange Factor (RCC1)
RCC1 Regulator of Chromosome Condensation
RIPA Radio Immunoprecipitation
RPMI Roswell Park Memorial Institute
SDS Sodium Dodecyl Sulfate
Sec Secretory
ss single stranded
SSC Sodium Chloride Sodium Citric Acid
STAT Signal Transducer and Activator of Transcription
T-ALL T Cell Acute Lymphoblastic Leukemia
TAE Tris Acetic Acid/Ethylenediaminetetraacetic Acid
TB  Transport Buffer
Tris Tris Hydroxymethylaminomethane
VSV Vesicular Stomatitis Virus
Y2H Yeast-Two-Hybrid
Jost Enninga- Nup98 and Nup96                                                                                       8
5. Introduction
5.1. General Introduction
The transport of molecules between the nucleus and the cytoplasm of
eukaryotic cells occurs through nuclear pore complexes (NPC). These are
highly regulated cellular structures that control nuclear entry and exit of
molecules such as transcription factors, RNAs, kinases and viral particles. In
general, to be imported or exported from the nucleus, molecules 1) bind to
transport receptors, 2) are transported through NPCs present in the nuclear
envelope (NE), 3) and translocate from the NPC to intranuclear or
cytoplasmic target sites. Although progress has been made regarding the
composition and mechanisms of the nuclear transport machinery, less is
known about the function and regulation of major constituents of the NPC.
NPCs are composed of proteins termed nucleoporins or Nups, which play a
role in the structure of the NPC and in regulating the translocation of
molecules through the NPC. In this thesis we characterize two major Nups
termed Nup98 and Nup96, which are encoded by the same gene. Nup98 is a
key controller of nuclear entry and exit of proteins and nucleic acids. Nup96 is
a component of a NPC subcomplex, however nothing is known about its
function.
5.2. The Nuclear Pore Complex- Its Structure and its Components
In eukaryotes, the nuclear pore complex (see figure 1 A-D) constitutes
the only gate for trafficking of molecules between the nucleus and the
cytoplasm (Blobel, 1995, Pemberton et al., 1998, Kaffman and O’Shea, 1999).
These 60 MDa (yeast) to 125 MDa (vertebrates) large proteinaceus structures
are among the largest multiprotein assemblies known so far. This is illustrated
by their size of about thirty times of a ribosome in vertebrates. The overall
architecture is highly conserved between yeast and mammals (Stoffler et al.,
1999, Ryan and Wente, 2000, Vasu and Forbes, 2001). Numbers of NPCs per
cell range from 200 NPCs in Saccaromyces cerevisiae, 5000 NPCs in
vertebrates , and to more than 5 millions NPCs in Xenopus oocytes
(Kubitscheck and Peters, 1998). Interestingly, the shape of NPCs does not
visibly vary within a cell or between different tissues (Maul et al., 1977 and
1980). However, functional studies and structure-function comparisons of
individual NPCs have been hampered by technical problems (discussed in
Peters, 2003).
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Figure 1: The vertebrate Nuclear Pore Complex (A) Schematics of the vertebrate
NPC. The cytoplasmic fibrils are highlighted in purple, the central transporter in
yellow and the nucleoplasmic basket in red. On the right side, the localization of
several nucleoporins is indicated. (B) Image analysis from isolated NPCs from
Xenopus (Radermacher et al., 1993). The eightfold symmetry, a central transporter or
plug, and the cytoplasmic and nucleoplasmic ring are shown. (C) FEISEM analysis
of NPCs from Xenopus Oocytes (Goldberg and Allen, 1996). The eightfold symmetry
and the nucleoplasmic basket (right side) can be seen. (D) Immuno electron
microscopy of isolated nuclear envelopes from rat liver nuclei. The NPCs are
positioned in the double membrane of the NE. Gold coupled secondary antibodies are
used to detect the nup specific primary antibodies.
Typically, the NPC has eightfold rotational and twofold axonal
symmetry leading to a stoichiometry of 16 copies of (almost) each protein per
complex (Kiseleva et al., 2000). Also, this symmetry reveals the architecture
of substructures of the pore complex consisting of cytoplasmic fibrils, a
central cylinder surrounded by spoke-ring like structures, and nucleoplasmic
fibrils connected with a terminal ring which is termed nuclear basket (figure
1). It has been proposed that filaments emanate from the nuclear basket into
the nuclear interior (Cordes et al. 1997, Fontoura et al., 2001). However, it is
uncertain whether these fibrils play a role in transport of cargo between
distinct nucleoplasmic regions, e.g. the nucleolus, and the nucleoplasmic side
of the NPC (Bangs et al., 1999, Carmo-Fonseca, 2002).
Over the past years all components of the NPC in Saccaromyces
cerevisiae (Rout et al., 2000), and more recently, all proteins constituting the
vertebrate NPC (Cronshaw et al., 2002) have been isolated and identified.
These proteins were collectively called nucleoporins (Nups). The yeast NPC
is comprised of 30 Nups (Rout et al., 2000), and the vertebrate NPC is
estimated to consist of approximately 40 Nups and NPC associated proteins
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Table 1: List of all vertebrate Nucleoporins, their localization, their motives and
diseases they are implicated in (Cronshaw et al., 2002)
(Fontoura et al., 1999 and Cronshaw et al., 2002). What defines essential
properties of Nups is still disputed, since numerous proteins only bind
temporarily to the NPC, indicating dynamic features of this structure
(Kaffman and O’Shea, 1999). For example, transport receptors termed
karyopherins (or importins, exportins and transportins) “contaminate”
fractions of highly purified NPCs (discussion in Rout et al., 2000). In addition,
it has recently been shown that some nucleoporins are not only located at the
NPC during interphase, but also inside the nucleus (Fontoura et al, 2001,
Griffis et al., 2002), suggesting more diverse roles for these proteins. So far,
the focus of the nuclear pore complex research has been on the molecular
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characterization of the nucleoporins to understand their role in
nucleocytoplasmic transport and their participation in NPC assembly and
dynamics.
Groups of Nups reside in NPC subcomplexes, which can be purified
biochemically and which are resistant to specific detergent treatments (Kita et
al., 1993, Guan et al., 1995, Siniossoglou et al., 2000, Matsuoka et al., 1999)
These subcomplexes are highly conserved between yeast and vertebrates and
will be described in a special section of this introduction. One way to classify
nucleoporins is by their sub-localization at the NPC (Ryan and Wente, 2000).
Some Nups are present on both sides of the NPC and some are found either at
the cytoplasmic or nucleoplasmic side of the NPC (Rout et al., 2000). Nups,
which are localized on both sides of the NPC, are either distributed equally at
the nucleoplasmic and cytoplasmic side or show an uneven distribution.
Nucleoporins can also be classified into families based on their
primary amino acid sequence (shown in table 1, Cronshaw et al., 2002). In
yeast, three families are known so far; the POMs, Non-FG-repeat-containing
Nups and FG-repeat-containing Nups (Phe-Gly, also called FxFG- and GLxG-
repeat-containing Nups). In vertebrates, a fourth family has been discovered
recently (Cronshaw et al., 2002). This new group contains Nups with WD-
repeat domains (Trp-Asp), which are implicated in protein-protein interaction
(Smith et al., 1999). The best-characterized group of Nups contains FG-
repeats, which are important in nuclear transport. They are present in one third
of all Nups, and they form a circle around the central channel (Rout et al.,
2000).
Nuclear import and export usually involves binding of transport
receptors (karyopherins or Kaps, importins, exportins, and transportins) to
cargos or substrates (molecules that enter or exit the nucleus which contain
nuclear localization signals, NLS, or nuclear export signals, NES,
respectively) followed by docking of the receptor-cargo complexes to the FG-
repeat-containing Nups. So far, only one crystal structure has been solved
examining the binding of the FG-repeats of Nup358 in complex with
karyopherinb1 (importinb, Bayliss et al., 2000). Assembly or disassembly of
the receptor-cargo complexes at the nuclear or cytoplasmic sides of the NPC
is mediated by the GTPase Ran, which exerts its function by binding to
transport receptors. Interconversion of RanGDP and RanGTP is regulated by
the Ran GTPase-activating protein 1 (RanGAP1) at the cytoplasmic side of
NPC and by the RanGDP/GTP exchange factor (RanGEF or RCC1, regulator
of chromatin condensation 1) localized predominantly in the nucleoplasm
with a fraction also found at the NPC (Fontoura et al., 2000). The specific
localization of RanGAP1 and RCC1 results in a high nucleoplasmic
concentration of RanGTP and a high cytoplasmic concentration of RanGDP.
Examples of nuclear transport pathways are shown in figure 2.
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Figure 2: Schematic representation of a nuclear import (left) and a nuclear export
pathway (right). Import of a classical NLS-bearing protein (S) is mediated by a
heterodimer of Kapa and Kapb1. Kapa interacts directly with the NLS, whereas
Kapb1 binds to Nups resulting in docking of the complex to the NPC. The presence
of RanGTP on the nuclear side of the NPC would cause binding of RanGTP to the
Kap and concomitant displacement of the NLS substrate. On the other hand, the
nuclear export of a leucine-rich NES-bearing substrate (S) involves the formation of
a ternary complex composed of this substrate (S), the export receptor Crm1 and
RanGTP. After translocation through the NPC, the ternary complex is then
disassembled by RanGTP hydrolysis at the cytoplasmic side of the NPC.
Interconversion of RanGDP and RanGTP is regulated by RanGAP1 and RanGEF.
Based on the arrangement of the FG-repeat containing Nups and their
binding properties three models of nucleocytoplasmic transport have been
proposed (reviewed in Rabut and Ellenberg, 2001, Weis, 2002). One model is
based on the asymmetrical distribution of some FG-repeat Nups at the
nucleoplasmic and cytoplasmic side of the NPC (Radu et al., 1995, Ben-
Efraim and Gerace, 2001). This model proposes directionality of transport
through an affinity-gradient of transport-receptor-cargo complexes with
various FG-repeat Nups (Ben-Efraim and Gerace, 2001). The other two
models are based on facilitated brownian diffusion through the NPC via the
high affinity of the FG-repeat Nups to the transport-receptor cargo complexes.
One model is called affinity-gate-model (Rout et al., 2001) and one is called
hydrophobic-exclusion-model (Ribbeck et al., 2001 and 2002, Gorlich et al.,
2003). The first one is based on the comprehensive analysis of the
components of the yeast NPC and their topology (Rout et al., 2001). The
second one is based on a detailed kinetic analysis of nucleocytoplasmic
shuttling in vertebrate cells (Ribbeck and Gorlich, 2001). Both models
highlight facilitated diffusion through the NPC, however they differ in the
detailed mechanism how the transport event occurs (Rabut and Ellenberg,
2001). The affinity-gate-model emphasizes the presence of an aqueous
channel bridging the nucleoplasm with the cytoplasm. After high-affinity-
binding to the FG-repeat-containing Nups the transport-receptor-cargo
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complexes traverse the aqueous channel or the central transporter. However,
the hydrophobic-exclusion-model proposes that the FG-repeat-containing
Nups cover the whole central transporter functioning as a molecular sieve,
which is only permeable for transport-receptor-cargo complexes. Importantly,
all these models do not consider Nups without FG-repeat regions. Some of
them are also connected to nucleocytoplasmic traffic (for example Bangs et
al., 1998), which adds more complexity to the system.
5.3. Methods to study the Nuclear Pore Complex
Since the coining of the term nuclear pore complex in 1959 (Watson,
1959) a plethora of biochemical, cell biological, genetical and physiological
methods have been applied to study different aspects of NPCs described in the
previous chapter, in particular their architecture, composition and function.
The earlier studies, which led to the discovery of the NPC as a unique
structure spanning the nuclear envelope connecting the nucleoplasm with the
cytoplasm, involved mainly electron microscopy methods of negatively
stained specimens from different eukaryote sources (reviewed in Wente,
2000). These techniques and freeze-fracture edging of nuclear envelopes
demonstrated the typical eightfold-symmetry of the NPC (Maul, 1971).
Furthermore, comparative electron microscopy (EM) analysis of specimens by
freeze fracture from various tissues and numerous organisms revealed that the
overall architecture of the NPC is conserved between tissues and organisms
(Maul et al., 1977 and 1980). However, these studies demonstrated an altering
number of NPCs per cell in different tissues and among the studied organisms.
Recently, imaging techniques of single particles performed by cryo electron
microscopy showed the differences of the yeast and the vertebrate NPC (Yang
et al., 1998). However, these studies have not yielded a detailed structure of
the whole NPC due to the limitation of resolution. Further details of the NPC
architecture were discovered through special electron microscopy techniques
such as FEISEM (field emission in lens electron microscopy), which
demonstrated the structure of the nuclear basket and the cytoplasmic filaments
emanating from the core structure of the NPC (Goldberg and Allen, 1996).
Biochemical fractionation techniques of vertebrate tissues revealed the
constituents of the nuclear envelope and the NPC. One breakthrough led to the
quick isolation of highly purified rat liver nuclei followed by the isolation of
nuclear envelopes from nuclei (Blobel and Potter, 1966, Dwyer and Blobel,
1976). The first protein identified as component of the NPC was p62, which
was discovered in 1986 (Davis and Blobel). Chromatographic separation
techniques from NE and NPC proteins led to the isolation of several
Nucleoporins (Radu et al., 1993). These studies were accelerated by the
annotation of the complete draft of the yeast genome and the complete draft of
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the human genome. In 2000, a proteomic analysis of the yeast NPC via
rigorous fractionation techniques, protein sequencing of separated proteins by
mass spectrometry, and the comparison of the obtained sequence data with
genomic databases gave its complete inventory (Rout et al., 2000). A similar
study was carried out on rat NPCs (Cronshaw et al., 2002) indicating that the
number of Nups does not vary significantly between yeast and vertebrates.
However, the advantage of the yeast approach was its combination with yeast
molecular biology techniques, such as genomic tagging of proteins, allowing
immunodetection and subsequentially localization of the tagged proteins at the
NPC.
Studies on the function of the NPC started with microinjection
techniques of fluorescent probes such as dextrans, revealing the diffusion
barrier of the NPC (Paine et al., 1975, Peters, 1984). These and subsequent
analyses profited from new developments in light microscopy such as laser
scanning confocal microscopy and deconvolution microscopy resulting in
better images of eukaryotic cells (reviewed in Conn, 1999). The advent of
molecular biology techniques and the discovery of specific nuclear
localization sequences (NLS) made it possible to study transport events in
detail (Kalderon et al., 1984). Chimeric fusion proteins with genetically
modified green fluorescent protein (GFP) from Aequoria victoria allowed
analysis of nucleocytoplasmic transport of virtually any protein of interest
(reviewed in Roberts and Goldberg, 1998). A breakthrough in the nuclear
transport field occurred when nuclear import assays were developed in
semipermeabilized cells, which led to the discovery of several import factors
and the involvement of the RanGTPase system in nucleocytoplasmic shuttling
(Adam et al., 1990). Recently, quantitative kinetic studies in HeLa cells by
time lapse microscopy led to a model on the functionality of the NPC
(Ribbeck and Gorlich, 2000 and 2001, Gorlich et al., 2002).
Even before the discovery of the NPC it was known that the nuclear
envelope disassembles at the onset of mitosis and reassembles at the end of
mitosis in higher eukaryotes. Later, it was recognized that higher eukaryotic
cells do not contain complete NPCs during mitosis (for example, Maul, 1977).
Therefore, several approaches have focused to understand the events that lead
to the assembly and disassembly of NPCs. Phosphorylation studies have been
used to investigate the disassembly of the NPC (Macaulay et al., 1995,
Kehlenbach and Gerace, 2000). However, most of the work has been focused
so far on studying the assembly after mitosis. An attractive system is Xenopus
egg extract, which can be used to study the assembly of pores and nuclear
envelopes (Forbes et al., 1983). Immunodepletion experiments in this system
resolved the role of individual proteins here (Walther et al., 2003, Harel et al.,
2003). Eukaryotic tissue culture cells can also be synchronized by various
methods (see Spector et al., 1998) to investigate NPC assembly processes via
time-lapse microscopy. The dynamic behavior of Nups throughout the cell
cycle has been investigated with bleaching techniques such as fluorescent
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recovery after photobleaching (FRAP) or fluorescent loss in photobleaching
(FLIP) (Belgareh et al., 2001). Furthermore, chimeric proteins between Nups
and GFP (described above) showed that some Nups are tightly attached with
the NPC in contrast to others, which are dynamic and move within the NPC or
even to other compartments in the cell (Daigle et al., 2001).
5.4. Subcomplexes of the Nuclear Pore Complex
Nups can be assembled in specific subcomplexes of the NPC, which
are conserved from yeast to vertebrates (Vasu and Forbes, 2000). Two of
these subcomplexes have been characterized so far. The vertebrate p62
subcomplex consists of the Nups p62, p54 and the alternatively spliced forms
p58 and p45 (Kita et al., 1993, Guan et al., 1995). In yeast, this subcomplex is
made of Nsp1, Nup57, Nup49, Nic96, Nup188 and Nup192 (Grandi et al.,
1995, Schlaich et al., 1997). It is also called the central transporter since it is
believed to be of great importance for regulated nucleocytoplasmic shuttling.
It will be crucial to study how this subcomplex is assembled into the overall
NPC structure, and how the structure of this subcomplex is related to its
transport properties.
Evidence of another subcomplex of mammalian Nups termed Nup107-
160-subcomplex emerged which contains Nup96, Nup107, Sec13, at least one
Sec13-related protein, and at least two additional proteins of ~150 kD
(Fontoura et al., 1999). Nup96 was immunoprecipitated with a novel
vertebrate nucleoporin termed Nup133 and the previously identified Nup107
(Belgareh et al., 2001). These results were corroborated by the isolation and
further characterization of the Nup107-160 subcomplex in Xenopus egg
extracts, which consists of Nup96, the novel nucleoporins Nup160, Nup107,
Nup133, Nup85 and Sec13 (Vasu et al., 2001). This subcomplex was first
identified in yeast as heptameric Y-shaped multiprotein structure and
designated Nup84p subcomplex as illustrated in figure 3 (Siniossoglou et al.,
1996 and 2000, Lutzmann et al., 2002). The Y-shaped fork of the complex is
formed by two contacts of Nup120p with the Nup85p arm and with C-
Nup145p, and the elongated fibril or stalk of the Y is constituted by C-
Nup145p-Sec13p-Nup84-Nup133 (Lutzmann et al., 2002). The whole Nup84p
subcomplex could be reassembled in vitro by co-expressing its constituents in
E. coli (Lutzmann et al., 2002).
Interestingly, Sec13 is a protein shared by two transport machineries,
ER to Golgi transport and nuclear transport. More recently, proteomic analysis
of the mammalian NPC also identified Sec13 as a constituent of the NPC
(Cronshaw et al., 2002), however, the molecular mechanisms involved in the
Sec13 function(s) have not been studied. Sec13 has been previously shown to
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Figure 3: The Nup84p subcomplex in S. cerevisiae and the Nup107-160 subcomplex
in H. sapiens (A) The Nup84p subcomplex was reconstituted from its components in
vitro yielding a Y-shaped heptamer (Lutzmann et al., 2002). (B) Schematics of the
vertebrate Nup107-160 subcomplex. Presumably, the Y-shape is conserved among
the different organisms. (C) Homology of the constituents between the Nup84p- and
the Nup107-160 subcomplex.
have a role in the biogenesis of COPII-coated vesicles, which mediate the
anterograde transport from the ER to the Golgi apparatus (Swaroop et al.,
1994, Shaywitz et al., 1997,  Tang et al., 1997, Hammond and Glick, 2000).
At the yeast NPC, Sec13 has functions related to nuclear pore complex
structure and organization, although the molecular mechanisms are not known
(Ryan and Wente, 2002).
Conflicting data exist on the localization of the Nup107-160
subcomplex constituents. First, Nup96 was localized to the nucleoplasmic side
of the NPC (Fontoura et al. 1999), however, the yeast homologue C-Nup145
was found on both sides of the NPC (Rout et al., 2000). Later studies
demonstrated that human Nup133 and Nup107 and their yeast homologues
were localized at both sides of the NPC (Belgareh et al., 2001). In contrast, the
analysis of the Nup107-160 subcomplex in Xenopus oocytes indicated an
exclusively nucleoplasmic localization (Vasu et al., 2001). These
contradictions will be addressed in this thesis.
Interestingly, the Nup107-160 subcomplex does not contain any FG-
repeat containing Nups, and only little is known about the function of its
individual constituents. Recently, studies in vertebrate cells and Xenopus
oocytes indicated a role for this complex in mRNA export (Vasu et al., 2001)
and possibly nuclear envelope assembly (Walther et al., 2003). This will be
reviewed in the next section.
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5.5. The Nuclear Pore Complex throughout the Cell Cycle
The genetic material of a single cell is duplicated throughout
interphase and after condensation the chromosomes are separated into two
daughter cells during mitosis. In yeast, which has a closed mitosis, the NE
does not break down and new nuclear pores are synthesized and embedded in
the NE constantly (Ryan and Wente, 2000, Strambio-de-Castillia and Rout,
2002). In contrast, vertebrates undergo an open mitosis with a breakdown of
the NE at early prophase (Weis, 2003). At the end of telophase the NE
reassembles in both daughter cells separating the cytoplasm from the
nucleoplasm. At the onset of the NE breakdown, proteins constituting the
intranuclear lamina and proteins of the NPC are phosphorylated which
appears to be critical for disruption of the NE (Gerace and Blobel, 1980,
Macaulay et al., 1995, Kehlenbach and Gerace, 2000). Recently, it has been
demonstrated that the generation of mechanical force from the spindle
apparatus is also required in this process (Beaudouin et al., 2002, Salina et al.,
2002). Importantly, the NPC is disassembled at the onset of an open mitosis
and reassembled at the end of telophase (Weis et al., 2003). However, Nups
are synthesized during S phase, which results in doubling the number of NPCs
(Ryan and Wente, 2000).
Two Nups, Nup133 and Nup107 have been implicated to stably
associate with the kinetochores during mitosis, though their function at those
sites has not been investigated so far (Belgareh et al., 2001). Hypothetically,
these Nups are either “passenger” proteins, which are carried along the
kinetochores during mitosis or they are actively involved in the events of cell
division. Also, no information is available on the mitotic behavior of other
components of the Nup107-160 subcomplex. Very recently, Nup107 and
Nup133 have been shown to be key players for NPC reassembly at the end of
mitosis (Walther et al., 2003). These studies involved immunodepletion
experiments and showed NEs without Nups (Walther et al., 2003). Other
depleting studies of Nup107 in vertebrate cell lines indicated no effect on the
mitotic behavior of Nup depleted cells (Boehmer et al., 2003). Importantly,
these studies revealed that depletion of a single Nup reduced the number of
several other Nups indicating that it is difficult to single out effects
particularly caused by one specific Nup.
5.6. The Nucleoporins Nup98 and Nup96
Three precursor proteins have been identified, which are derived from
alternative splicing of a primary transcript termed Nup98-Nup96 as can be
seen in the schematics of figure 4 (see also Enninga et al., 2002). The three
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precursor-protein isoforms are then autocatalytically proteolyzed at a defined
site, yielding the mature Nups which remain non-covalently associated
(Fontoura et al., 1999, Rosenblum and Blobel, 1999). The Nup98 precursor
protein is cleaved at the C-terminus (cleavage site shown by the arrowhead),
generating Nup98 and a 6 kD carboxy terminal polypeptide, while the Nup98-
Nup96 precursor is cleaved at the same site generating Nup98 and Nup96.
Similarly, the Nup98-p87 precursor is cleaved yielding Nup98 and p87 (our
own observation).
It has been shown that the autoproteolytic cleavage resides between
F863 and S864 (Rosenblum and Blobel, 1999). The autoproteolytic
mechanism of the Nup98-Nup96 protein precursor is highly conserved and
widely spread among organisms. In S. cerevisiae, the homologue of the
Nup98-Nup96 precursor is called Nup145 (Wente and Blobel, 1994, Emtage
et al., 1997, Teixeira et al, 1997) which yields a 65 kDa N-Nup145 and a 80
kDa C-Nup145 through autocleavage (Teixeira et al., 1999).
N-Nup145 is the homologue of vertebrate Nup98 in S. cerevisiae.
Furthermore, two additional homologues have been identified in S. cerevisiae
named Nup100 and Nup116 (Emtage et al., 1997, Bailer et al., 1998). These
two Nups have been implicated in karyopherin mediated nucleocytoplasmic
transport. However, only Nup116, like Nup98, carries a GLEBS-like
sequence, which binds to the mRNA export factor Gle2p (Bailer et al., 1998).
So far, it is unclear why the vertebrate Nup98 has three homologous proteins
in yeast.
C-Nup145 is closely related to Nup96 and has been shown to have a
role as a scaffold protein and also in mRNA export (Wente and Blobel, 1994;
Dockendorff et al., 1997). However, the underlying experimental evidence
was based on genetic mutation analysis (Dockendorff et al, 1997).
Interestingly, C-Nup145 appears as part of a Y-shaped subcomplex of the
NPC, named Nup84p complex, which has been discussed above (Siniossoglou
et al., 2000).
In S. cerevisiae N-Nup145 and C-Nup145 have been localized to both
sides of the NPC (Rout et al., 2000). N-Nup145 has been shown to be present
more prominently at the nucleoplasmic side of the NPC (Rout et al., 2000).
Nup98 and Nup96 were localized to the nucleoplasmic side of the NPC at or
near the nucleoplasmic basket (Radu et al., 1995, Fontoura et al., 1999). The
correct targeting of both Nup98 and Nup96 to the NPC is dependent on
autoproteolytic cleavage, suggesting that the cleavage process may regulate
NPC assembly (Rosenblum and Blobel, 1999, Hodel et al., 2002). Indirect
immunofluorescence studies revealed additional localization of Nup98 and
Nup96 at intranuclear sites (Fontoura et al., 1999, Griffis et al., 2002).
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Figure 4: Gene expression of the Nup98-Nup96 gene. Three precursor proteins are
known so far which are derived through alternative splicing. The GLEBS motive is
marked in yellow, an RCC1 binding side in orange, the 6kDa region in red, and an
alternatively spliced 9kDa region in purple. The autoproteolytic cleavage site is
indicated with the arrowhead and the resulting proteins are shown on the right side
yielding Nup98, Nup96, the 6kDa region, and p87. The Nup98-Nup96 precursor is
the most abundant one (our own observation).
Nup98 contains FG-repeats, which bind karyopherins, and therefore
Nup98 has been implicated in karyopherin-mediated nucleocytoplasmic
transport. Nup98 binds to RCC1, which is hypothesized to be important for
the release of imported karyopherin-cargo complexes by exchanging GTP for
GDP in the small GTPase Ran (Fontoura et al., 2000). In addition to its role in
protein shuttling between the nucleus and the cytoplasm Nup98 binds to
mRNA export factors like RAE1 and a complex consisting of the mRNA
export receptors Mex67/TAP, RAE1 and Nup98 have been demonstrated
(Wang et al., 2001, Blevins et al., 2003). Nup98 also binds to tpr which is part
of the filaments connecting the NPC with the nuclear interior (Fontoura et al.,
2001). Studies demonstrated the importance of Nup98 in the export of the
HIV rev protein (Zolotukhin and Felber, 1999). These experiments revealed
that Nup98 could potentially shuttle between the nucleus and the cytoplasm.
The mobility of Nup98 was demonstrated later using photobleaching
techniques (Griffis et al., 2002). These experiments were performed in the
presence of transcription inhibitors revealing that the shuttling of Nup98 is
dependent on active transcription. Recently, Nup98 has been also shown to
bind to the vesicular stomatitis virus matrix protein (VSV M protein, see
figure 5, von Kobbe et al., 2000). It had been previously shown that M
proteins interfere with nucleocytoplasmic trafficking and this study revealed a
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direct link of viral proteins with the NPC (Her et al., 1997, Petersen et al.,
2000). Moreover, Nup98 is found in chromosomal translocations associated
with acute myeloid leukemias (AML) as will be discussed below (Ahuja et al.,
2001, Lam and Aplan, 2001 ). Overall, Nup98 is a multifunctional protein and
is of pathological importance in viral infections and cancer.
Although Nup96 has been previously identified by Fontoura and
colleagues (1999), it has not been characterized so far. In these studies rat
liver nuclei were isolated and NPCs were purified. The NPC proteins were
then separated on SDS-PAGE and a major band of approximately 115 kDa
was isolated and its peptide sequence was obtained. This sequence was
identical with a sequence obtained from a partial clone from an interferon g 
induced macrophage subtraction library (published by Yang et al., 1995). By
using this clone as template, a HeLa cDNA library was screened and two
mRNAs for Nup98/Nup96 precursor and Nup98/p87 precursor were
identified.
5.7. Role of Nucleoporins in Disease: Leukemia and Viral Infection
paradigms
In addition to their roles in physiological processes, Nups are also
important in several pathological states. Here, the focus is on gene fusions
resulting from chromosomal translocations and on the targeting of specific
Nups by viral gene products.
Importantly, Nups are target of at least 12 chromosomal
rearrangements in leukemia including chronic myelogenous leukemia (CML),
acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and
T cell acute lymphoblastic leukemia (T-ALL) (Ahuja et al., 2001, Lam and
Aplan, 2001). Interestingly, 10 of these rearrangements involve Nup98 and
two involve Nup214 (also known as CAN) (Lam and Aplan, 2001).
Strikingly, the N terminal region of Nup98, which binds transport receptors, is
the region present in all leukemia-associated Nup98 fusions that have been
characterized to date (Radu et al., 1995, Fontoura et al., 2000). This indicates
that the role of Nups in the pathogenesis of leukemia is related to their
function in nuclear transport. Moreover, in the case of the Nup98-HOXA9
fusion, Nup98 can up-regulate the transcriptional activity of HOXA9 by
binding to CBP/p300 (Kasper et al., 1999). The Nup98-HOXA9 fusion was
expressed in hemopoietic stem cells and was able to induce chronic and
myeloid leukemias in mice, demonstrating once again a role for Nups in
regulating cell growth resulting in hematologic malignancies (Kroon et al.,
2001). Disruption of the murine Nup98 protein demonstrated that Nup98 is
essential for mouse gastrulation, which requires rapid cell growth (Wu et al.,
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Figure 5: The Vesicular Stomatitis Virus (A) Electron micrograph of negatively
stained virions. The typical bullet shape of the VSV is shown (Wagner, 1987). (B)
Schematics of the VSV particles. The virus consists of 5 proteins and a (-)-RNA
molecule. The proteins are called G, L, M, N, and P. The M protein has been shown
to interact with Nup98 (von Kobbe et al., 2001).
2001). In addition, assemble of a subset of Nups into the NPC was affected in
Nup98 knock-out cells, leading to their accumulation in annulate lamellae and
resulting in altered stoichiometry and function of the NPC (Wu et al., 2001).
Consequently, major nuclear import and export pathways were also defective
in Nup98 knock-out cells (Wu et al., 2001). Thus, nuclear factors, especially
transcriptional regulators, are important for myeloid differentiation, and
disturbance in their nucleocytoplasmic transport may block differentiation and
lead to leukemia.
Regulation of the nuclear transport machinery is a new avenue of
studies that has recently been explored. Regulation of receptor-cargo complex
formation by phosphorylation or other factors such as calcium influx
constitute a key step for determining nuclear entry or exit of certain
transcription factors and kinases (Kaffman and O’Shea, 1999). In addition,
regulation of the NPC itself has been demonstrated by several findings.
Poliovirus and rhinovirus can induce degradation of at least two nucleoporins
leading to cytoplasmic accumulation of shuttling and non-shuttling nuclear
proteins (Gustin and Sarnow, 2001 and 2002), and the matrix (M) protein of
the vesicular stomatitis virus (VSV) binds Nup98 and inhibits nuclear export
of poly (A) RNA (see figure 5 for schematics of the VSV, Her et al., 1997,
Petersen et al., 2000, von Kobbe et al., 2000). Furthermore, Petersen et al
(2001) demonstrated that multiple vesiculoviral matrix proteins block
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transport of spliced mRNA, small nuclear RNAs, small ribonucleoporins and
reduced the rate of transport pathways dependent on Crm1, TAP and Kapb1
(importin b). Altogether, these findings place the nuclear transport machinery
at the center stage for regulation by signaling pathways and viruses, and Nups
are major targets of regulatory pathways.
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6. Objective of this thesis
Our long-range goal is to understand the molecular mechanisms of the
nuclear transport machinery, and how they are regulated by different signaling
pathways. The central hypothesis is that a subset of Nups are highly regulated
by extracellular signals, facilitate nuclear import and export of molecules, and
are also target of viral proteins and other pathogenic factors. We will focus on
two major constituents of the NPC, the nucleoporins Nup98 and Nup96, and
pursue the following specific aims:
1. Analysis of the intracellular distribution of Nup98 and Nup96
Previous studies have localized Nup98 and Nup96 exclusively to the
nucleoplasmic side of the NPC and to additional intranuclear sites. Models of
nucleocytoplasmic transport have been hypothesized based on this specific
localization. Recently, studies on the dynamics of Nup98 between the nucleus
and the cytoplasm have shown that Nup98 is a mobile Nup. Furthermore,
Nup96 has been shown as a constituent of a subcomplex which can be found
on the cytoplasmic and nucleoplasmic side of the NPC. We will show here a
detailed analysis on the localization of Nup98 and Nup96 with new antibodies
and new extraction methods:
1.1. Production of antibodies which can differentially recognize
specific alternative splice forms of Nup96. These antibodies will be used in
indirect immunofluorescence studies and in ultrastructural analyses.
Furthermore, these antibodies will be used to study the regulation of Nup96
expression as described in 2.
1.2. Intracellular localization of Nup98. Previously developed antibodies
will be used in indirect immunofluorescence and immuno electron microscopy
to further analyze the localization of this protein. New methods for the
isolation of nuclear envelopes, and fixation and permeabilization procedures
will be shown.
2. Studies on the molecular mechanisms involved in the
disruption of Nup98 and Nup96 function by a viral protein and
their regulation by the interferon (IFN) pathway
The vesicular stomatitis virus (VSV) matrix (M) protein binds Nup98
and inhibits nuclear export of mRNA. Interestingly, previous data suggested
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regulation of Nup98/Nup96 gene expression by IFN. IFNs are well known as
key regulators of antiviral responses. We will analyze:
2.1. Regulation of the Nup98/Nup96 gene expression by IFNs and
other cytokines.Various cell types will be treated with a number of cytokines
and their effect on the Nup98 and Nup96 protein and mRNA amounts will be
investigated. Furthermore, the signaling pathways involved in this process
will also be studied here.
2.2. Nup98 and Nup96 gene regulation and antiviral response. In-
situ hybridization studies will be performed in cells which have been
challenged with the VSV M protein and have been treated with IFNs to
monitor mRNA localization. Reporter gene assays will be performed in
Nup98 and Nup96 overexpressing cells that have been transfected with the M
protein to investigate the role of high amounts of Nup98 and Nup96 in gene
expression and antiviral response
3. Characterization of Sec13 and novel constituents of the
Nup98 and Nup96-mediated nuclear transport pathway(s)
Progress has been made on Nup98 function, however, the role of
Nup96 in nuclear transport remains to be elucidated. To investiate the function
of Nup96 we will pursue the following:
3.1. Identification and characterization of Nup96 interacting
partners will be performed by the yeast two-hybrid system, in vitro binding
assays accompanied by mutagenesis analysis, in vivo pull-down assays, and
tandem mass spectrometry identification.
3.2. Intracellular localization of proteins will be analyzed by
immunofluorescence and confocal microscopy of endogenous and ectopically
expressed proteins, and immuno electronmicroscopy.
3.3. Dynamic behavior of the constituents of this pathway will be
studied by time-lapse microscopy and bleaching techniques performed in cells
transfected with protein-GFP chimeras.
Thus, our research proposes innovative findings on Nup function and
regulation, which are crucial to advance the nuclear transport field and are
also essential for understanding the role of Nups in IFN-mediated processes,
such as antiviral response, innate immunity and cell proliferation.
Jost Enninga- Nup98 and Nup96                                                                                     25
7. Materials and Methods
7.1. Molecular Biology
7.1.1. Plasmid Construction
Wild-type Nup98 and Nup96 were cloned into myc-pAlter-MAX as
described (Fontoura et al., 2000). The Nup96 truncation mutants (amino acids
1-427; 53-427; 1-200; 53-200; 201-427; 428-849) were generated by PCR
using the wild-type Nup98-96 cDNA (Accession: AF071076) as template and
cloned into the SalI/NotI sites of myc-pAlter-MAX (PROMEGA). The GST-
Sec13 fusion encoding full length Sec13 (amino acids 1-322) and the deletion
mutants of Sec13 (amino acids 244-322, amino acids 1-302; and amino acids
301-322) were generated by PCR using wild-type Sec13 cDNA as template
(kindly provided by D. I. Smith, University of Michigan, Ann Arbor, MI,
Accession: NP_109598) and cloned into the BamHI/NotI sites of pGEX4T3
(AMERSHAM). The GST-Nup98 (amino acids 519-869) was generated by
PCR using wild-type Nup98-Nup96 cDNA as template and cloned into the
pGEX4T3. The GST-Nup96 (amino acids 1292-1484, and amino acids 1485-
1562) were generated by PCR using the wild-type Nup96 cDNA as template
and cloned into the SalI/NotI sites of pGEX4T3. Sec13-GFP fusion encoding
the full length Sec13 (amino acids 1-322) was generated by PCR using full
length Sec13 as template and cloned into EcoRI/Bam HI sites of pEGFP N1
(CLONTECH). The myc-tagged PK (pyruvate kinase)-Sec13 fusions (amino
acids 1-322; amino acids 1-243; amino acids 244-322; 1-302; and amino acids
301-322) were generated by PCR using full length Sec13 as template and
cloned into EcoRI/XhoI sites of pcDNA1-mycPK (kindly provided M.
Michael, University of California, San Diego, CA) The PML-EGFP plasmid
was kindly provided by P. P. Pandolfi (Memorial Sloan Kettering Cancer
Center, New York, NY). All constructs were sequenced at the Rockefeller
University or at the University of Miami DNA sequencing facilities.
The cloning procedures were performed as described by Sambrook
(1989). Briefly: Double stranded DNA was obtained by PCR using vectors as
template which contained the gene of interest. The primers were designed for
the DNA regions described in the last paragraph (24 nucleotides overlap) with
additional nucleotides for the designated restriction enzyme sites. The reading
frame of the plasmid vector DNA and the gene of interest were also carefully
monitored during the primerdesign. 100 ng template DNA was mixed with 1
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mg 5’-primer, 1 mg 3’-primer, 40 mM dNTPs, 10 ml MgCl2 containing PCR
buffer (ROCHE) for a 100 ml reaction with 1 ml High Fidelity Polymerase (2.5
U/ml, ROCHE). The dsDNA was amplified in 25 cycles at 52°C (45 s)
annealing temperature, at 72°C reaction temperature (1000 base pairs per
minute depending on the reaction) and at 95°C denaturation temperature.
After the last cycle the reaction was extended for 10 min to generate dsDNA
molecules from remaining ssDNA molecules in the reaction mix. The PCR
products were purified with a “PCR clean up kit” according to the
manufacturer’s instruction (QIAGEN). The purified dsDNA and the vector
plasmid were digested in 100 ml restriction enzyme reactions using the
enzymes mentioned above and reaction conditions as recommended by New
England Biolabs. After 6 h digestion reaction at 37°C, the digested DNA
molecules were separated by 1% agarose gel electrophoresis in 1 x TAE
buffer (40 mM Tris·acetate, 2 mM Na2EDTA•2H2O, pH=8.5) supplemented
with 0.2 mg/ml ethidiumbromide following standard procedures (Sambrook et
al., 1989). Fluorescently visible bands were cut out with razor blades and
DNA was extracted from the gel with a commercial “DNA extraction kit”
(QIAGEN) according to the instructions. For ligation reactions 0.1 pmol of
digested plasmid was mixed with 0.5 pmol digested insert DNA in a 20 ml
reaction using T4 DNA ligase (NEB) in ATP containing ligation buffer (NEB)
for 3 h at room temperature. 2 ml of this reaction were directly used for
transformation of 50 ml ultracompetent DH5a  cells (INVITROGEN)
following standard procedures (Sambrook et al., 1989). Transformed bacteria
were plated on antibiotic containing LB plates, and clones were picked the
following day. DNA was isolated from bacteria with commercial Miniprep
kits following the instructions (QIAGEN). DNA was analyzed by restriction
enzyme digestion, and by DNA sequencing.
7.1.2. Northern Blotting
Nup96 and p87 probes were prepared by PCR, gel-extracted, labeled and
purified. Briefly, the dsDNA probe was amplified by PCR as described in
plasmid construction, the PCR product was analyzed on a 1% agarose gel (see
above), and fluorescent bands were extracted with a commercially available kit
(GENECLEAN). Three volumes of NaI containing extraction solution
(GENECLEAN) were incubated with the gel-pieces at 55°C for 10min. Then,
10ml of glassbeads (GENECLEAN) were added to bind the DNA at room
temperature for 5 min. After washing the beads three times with new wash
solution (GENECLEAN), DNA was eluted with 10ml H20.
50 ng of Nup96 and p87 cDNAs were labeled with 50 mCi of [32P]-a-
dCTP using a commercial kit (STRATAGENE). The DNA was added to 40 ml
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reaction spheres (STRATAGENE) and heated at 95°C for five minutes for
denaturation. Then, 50 mCi [32P]-dCTP (AMERSHAM) and 1ml Magenta-
DNA-polymerase (10 U/ml, STRATAGENE) were added, and the reaction
was incubated at 37°C. Finally the stop-solution (STRATAGENE) was added,
and the enzyme was inactivated by heating 95°C for five minutes. The labeled
probe was purified by seize-exclusion chromatography using the Chromaspin-
30 kit from Clontech according to the instructions (CLONTECH).
Human multiple tissue northern blots (MTN-blots) were obtained from
Clontech and incubated in pre-hybridization solution (CLONTECH) for 1 hr
at 65°C. The purified probe (2 x 106 cpm) was supplemented with sheared
salmon testes DNA (100mg, Sigma) after incubation at 95°C for 5 min, and
then left on ice for 5 min. The probe was incubated for 1 hr with the
membranes at 65°C in pre-hybridization solution. Membranes were then
washed twice in 2 x SSC (20 x SSC: 3M NaCl; 0.3M sodium citrate, pH=7.0),
incubated 15 min in 1 x SSC, 0.1% SDS and 15 min in 0.2 x SSC, 0.1% SDS
at 25°C. Blots were finally autoradiographed approximately for 4 days.
7.1.3. Semiquantitative RT-PCR
RNA was extracted from U937 cells with the RNeasy RNA-
preparation-kit (QIAGEN) according to the instructions given by the
company. RNA amounts and purity were measured with an UV-spectrometer
(BIORAD) at 260nm and 260nm/280nm, respectively. Concentrations were
calculated using the equation c= OD260nm x 40mg/ml.
For first strand synthesis 100 ng of the prepared RNA were incubated
with 1ml of 100 ng/ml nonamer oligo-dT primer, 1ml 40mM dNTPs, and
MMLVT-RT buffer (STRATAGENE) in a total volume of 9.5ml. Secondary
RNA structures were denatured by incubation at 70°C for 10min. 0.5ml
MMLV-reverse-transcriptase (20U/ml, STRATAGENE) were added after
cooling the reaction mix at room temperature for 5 minutes. The mixture was
incubated at 37°C for 60min, at 70°C for 15min and on ice for 1 min. The
obtained cDNA products were used for PCR analysis. A fragment from base
4424 to base 5074 of the Nup98/Nup96 cDNA was amplified (sense primer:
5’-GTATGAAGAAGCATTTCAGAATAC-3’, antisense primer: 5’-
GTATGAAGAAGCATTTCAGAATAC-3’). Additionally, the amount of b-
tubulin cDNA was analyzed as a control (sense primer 5’-
TTCCCTGGCCAGCTCAATGCTGACCTCCGCAAG-3’ (bp 3449-3481),
antisense primer 5’-GCCTTCCTCCACTGGTACACAGGCGAGGGCATG-
3’ (bp 3902-3934)). The PCR reaction mixture consisted of: 1ml first strand
reaction, 5ml 10x Pfu-buffer (STRATAGENE), 1ml (40mM) dNTPs, 1ml
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(1mg) Nup96 sense- and antisense-primers [or 1ml (1mg) b-tubulin sense and
antisense-primers], 1ml Pfu-polymerase (2.5U/ml, STRATAGENE), and
water was added to a final volume of 50 ml. Cycling conditions were chosen
as follows: 1 min at 94°C; 35¥ (30s at 94°C, 1min at 59°C for Nup96 primers
or 1min at 66°C for b-tubulin primers, 2min at 72°C); and 10min at 72°C.
15ml of each PCR reaction were electrophoresed on a 1% agarose gel as
described elsewhere in this section. Bands were analyzed by ethidium
bromide staining and UV-excited fluorescence.
7.1.4. Yeast Two Hybrid Assay
The yeast two-hybrid (Y2H) screenings (Fields and Song, 1989) were
performed in the Molecular Interaction Facility (MIF), UW-Madison
according to their protocols. The yeast strains and vectors have been
previously described (James et al., 1996). Bait preparation: Nup96 (amino
acids 1-378) was cloned in-frame with the GAL4 DNA-binding domain of
bait vector pBUTE (a kanamycin-resistant version of GAL4 bait vector
pGBDUC1). The resulting vector was automatically sequenced by standard
protocols to confirm an in-frame fusion, then transformed into mating type A
of strain pJ694 and tested for autoactivation of the ß-galactosidase reporter
gene. Library screen: The screenings were conducted using the MIF human
library collection representing cDNAs from B-cell, breast, prostate and
placenta tissues. Approximately fifty-million clones were screened via mating.
Of these, six yeast clones tested positive for interaction via selection on
histidine drop-out and ß-galactosidase assay. Plasmids were rescued and
analyzed by restriction digest using standard protocols (Sambrook et al.,
1989). Six isolated prey plasmids were re-transformed into the alpha mating
type of PJ694 and validated in a mating and selection assay with the Nup96
bait, the empty bait vector and unrelated baits. Five clones were positive (they
grew in interaction selection media and were ß-gal positive) in the validation
test and subsequently were identified via sequencing.
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7.2. Biochemistry
7.2.1. Preparation of Nuclear Envelopes from Rat Liver
Nuclei were purified from rat liver as described by Blobel and Potter
(1966): Rats were asphyxiated with CO2 for 15 to 20 seconds, and were then
decapitated with a guillotine. The livers were isolated, placed into ice-cold
low sucrose buffer (0.25M sucrose, 50mM Tris-HCl pH 7.5, 25mM KCl,
5mM MgCl2,  1mM DTT,  0 .5M PMSF and  1mg/ml
leupeptin/aprotinin/pepstatin) and minced with razor blades. Then, 1 volume
of minced liver and 2 volumes of the same buffer were homogenized in a
Potter-Elvehjem homogenizer (0.025 cm clearance) for 15 full strokes at
1,700 rpm. The homogenate was filtered through 4 layers of cheese cloth and
centrifuged at 800 g for 15 min at 4°C. 1 volume of loose pellet was mixed
with 2 volumes of high sucrose buffer (2.3M sucrose, 50mM Tris-HCl pH 7.5,
25mM KCl, 5mM MgCl2, 1mM DTT, 0.5M PMSF and 1m g/ml
leupeptin/aprotinin/pepstatin) before overlaying 1 part of high sucrose buffer
with 5 parts of the initial mixture and ultra-centrifuged at 28000 rpm for 1 h at
4°C in a SW-28 rotor (BECKMAN). The nuclei containing pellet was
resuspended in the low sucrose buffer and was again homogenized with 2 full
strokes as described above. This homogenate was centrifuged at 800 g for 15
min at 4°C and the pellet contained the highly purified rat liver nuclei. These
nuclei were resuspended in the low sucrose buffer, and aliquots were stored at
–80 °C. The number of nuclei was determined by measuring the OD260
(OD260=1 equals 3 x 106 nuclei).
For the nuclear envelope preparation nuclei were thawed and pelleted
at 500 rpm in a tabletop microfuge for 1 min. After removing the supernatant,
the pellet was resuspended to a final concentration of 100 U/ml by drop-wise
addition of cold resuspension solution (0.1 mM MgCl2, 0.5 mM PMSF, 1
mg/ml leupeptin/pepstatinA/aprotinin, 5 mg/ml DNase I (SIGMA), and 5
mg/ml RNase A (SIGMA) with constant vortexing. The nuclei were then
immediately diluted to 20 U/ml by addition of ice-cold low sucrose solution A
(10% sucrose, 20 mM triethanolamine (pH 8.5), 0.1 mM MgCl2, 1 mM DTT
and protease inhibitors), again with constant vortexing. The suspension was
dounced four times in a glass dounce homogenizer (tight pestle) and incubated
at room temperature for 15 min. After the 15 min incubation, the suspension
was underlaid with 5 ml of ice-cold high sucrose solution (30% sucrose, 20
mM triethanolamine, pH 7.5, 0.1 mM MgCl2, 1 mM DTT and protease
inhibitors) and centrifuged at 4,100 g in a swinging bucket rotor (SORVALL,
HB-4) for 15 min at 4°C. After removing the supernatant and sucrose cushion,
the pellet was resuspended to a final concentration of 100 U/ml in ice-cold
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low sucrose solution B (10% sucrose, 20!mM triethanolamine, pH 7.5, 0.1
mM MgCl2, 1 mM DTT and protease inhibitors). The pellet resulting from
this extraction was operationally defined as the nuclear envelope fraction.
7.2.2. Protein Expression, In-Vitro-Binding and Immuno-
precipitation
Glutathione-S-transferase (GST) fused with full length Sec13 (amino
acids 1-322), or with the carboxy terminus of Sec13 (amino acids 244-322), or
with the carboxy terminus of Nup98 (amino acids 519-869), or with two
regions of Nup96 (amino acids 1291-1482 or amino acids 1485-1559) were
expressed in E. coli BL21 D3 (INVITROGEN) following standard protein
expression protocols (Sambrook et al., 1989). Expression of recombinant
protein was induced with IPTG (isopropyl-1-thio-b-D-galactose) at a
concentration of 0.1 mM at 37°C for 3 h. For purification of the proteins
bacteria were centrifuged for 15 minutes (7000g at 4°C) and the pellet was
stored at –80°C. To lyse the cells, the pellet was resuspended in ice-cold TB
(transport buffer; 20 mM HEPES, pH=7.4, 110mM potassium acetate; 2mM
MgCl2), and the suspension was passed two times through a French-press
(10000 psi). The disrupted cells were centrifuged for 20 minutes (26000 g at
4°C), and the supernatant was incubated with 4 ml glutathione-sepharose-
beads B4 (PHARMACIA) for two hours at 4°C. After centrifugation at 3000g
for 5 min, the supernatant was carefully removed and the beads were washed
four times with at least five volumes TB .The purified fusion proteins were
either used directly bound to the sepharose beads for in vitro binding assays,
or the fusion proteins were eluted with TB containing 10 mM reduced
glutathione or with SDS sample buffer (0.5% SDS w/v; 0.05M Tris/HCl
pH=8.0; 1mM DDT, 0.1% bromophenol blue). Sec13 (amino acids 244-322)
and Nup96 (amino acids 1485-1559) were used for antibody production as
described in a special section in this introduction.
In vitro binding reactions were carried out as described elsewhere
(Fontoura et al., 2000) using recombinantly expressed GST-Sec13 full length
protein and in vitro transcribed and translated Nup96 proteins as indicated in
the figure legends. All wild-type and mutant Nup98 and Nup96 proteins were
in vitro transcribed and translated using a coupled reticulocyte lysate
transcription/translation system (PROMEGA), in the presence of [35S]
methionine, according to the manufacturer’s instructions.Bound and unbound
fractions were separated on SDS-PAGE and analyzed by autoradiography.
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To determine the specificities of the Nup96 and Nup96/p87 antibodies,
immunoprecipitation experiments were performed. [35S] methionine labeled
Nup96 and p87 proteins, obtained by in vitro transcription and translation
reactions (PROMEGA), were incubated with a-Nup96 and a-Nup96/p87
antibodies (1 hr, 4˚C) and were then incubated with protein-A-sepharose
(PHARMACIA) for precipitation (1 hr, 4˚C). After centrifugation, the
supernatant was defined as unbound fraction. The beads were washed four
times in TB-T-buffer (TB containing 0.1% Tween 20) and were then heated in
SDS-sample-buffer. Bound and unbound fractions were separated on 4-20%
SDS-PAGE (NOVEX, INVITROGEN), the gels were stained with Comassie
Brilliant Blue solution, incubated with Enlightning Solution (NEN Life
Sciences), dried and exposed for X-ray autoradiography.
7.2.3. Immunoblot Analysis
Whole cell lysates were prepared from either HeLa cells, U937 cells or
from mouse embryo fibroblasts. Two procedures were used leading to the
same results. In the first method, cells were disrupted by alkaline lysis.
Approximately, about 2x106 cells were harvested, washed three times in ice-
cold PBS and lysed in 90m l 0.4N NaOH on ice. The cell lysate was
immediately neutralized with the same volume of 0.4N HCl on ice and the
samples were frozen in liquid nitrogen to prevent proteolysis and to shear
DNA. After thawing the lysates on ice, they were centrifuged at 12000 g for
15 min at 4°C, and the supernatants were defined as whole cell lysate.
Alternatively, cells were lysed with RIPA buffer. Cells were washed
twice with cold PBS and harvested in ice-cold PBS containing protease
inhibitors (Complete Mini EDTA-free, ROCHE) using a cell scraper. After
centrifugation at 3000 rpm for 5 min at 4°C, the supernatants were decanted
and the cell pellets were frozen in liquid nitrogen to shear the DNA. Then, the
frozen cell pellets were thawed on ice and lysed in RIPA buffer (150mM
NaCl, 50mM Tris/HCl pH 8.0, 0.5mM EDTA, 0.5% deoxycholate, 0.1% SDS,
0.5% NP-40, protease inhibitors mix). The lysates were sonicated twice for 5
sec (Micro Ultrasonic Cell Disruptor, KONTES) and incubated for 10 min at
65°C. After centrifugation at 14,000 rpm for 15 min at 4°C, the supernatants
were diluted with 4x SDS-PAGE sample buffer.
Protein concentration was determined by the Bradford assay
(BIORAD) according to the company’s instructions, and equal amounts of
proteins were separated by SDS-PAGE on 8% gels (NOVEX, INVITROGEN)
and transferred to PVDF membranes (IMMOBILON) or to nitrocellulose
membranes (SCHLEICHER & SCHULL) as previously described (Sambrook
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et al., 1989, Dreyfuss et al., 1984). After treatment with 100 % methanol for
15 min, PVDF membranes were blocked for 30 minutes with 5% nonfat dry
milk in PBS, supplemented with 0.05% NP-40. The nitrocellulose membranes
were NOT treated with 100 % methanol, but all other treatments were the
same.  The blots were probed with primary antibodies as indicated in the
results section (dilutions of the antibodies are depicted in table 2) in PBS
containing 2% BSA. Secondary a-rabbit or a-mouse IgG antibodies
(depending on the source of the primary antibodies, see table) diluted 1/20000
in PBS/5% nonfat dried milk (incubated for 45 minutes) were detected using
luminol-based chemiluminescence (PIERCE) according to the instructions.
7.2.4. Antibody Production and Purification
In the course of this study two novel antibodies were generated, one
against Nup96, which does not recognize the other known spliced isoform
p87, and one against the C-terminus of Sec13.
Purified GST-fusion-proteins were sent to Cocalico Biologicals (PA)
to raise antibodies in rabbit. For the initial inoculation 100 mg of antigen
(fusion protein) was injected with Freund’s Adjuvant solution to boost the
immune response. Further boosts with 50 mg of antigen were performed 14
days, 21 days, 35 days and 49 days after the initial inoculation. All sera
obtained (the first testbleed was obtained 35 days after the initial inoculation)
were used for immuno blotting on whole cell lysates from HeLa cells.
For affinity purification, 10mg of purified Nup96 (amino acids 1485-
1562) or Sec13 (amino acids 244-322) were transferred to a nitrocellulose
membrane (BIORAD) according to the immuno blot protocols described in
this section. After staining with Ponceau-S (for one liter: 5g Ponceau S, 10ml
glacial acetic acid, add H2O), membrane pieces containing the protein were
blocked for 1 h with 2% BSA in PBS, and incubated with antiserum at 4˚C
overnight. The next day the filter was washed six times with ice-cold PBS and
four times with PBS/1M NaCl. For elution of bound antibodies two
procedures were applied. First, membranes were heated at 56˚C for 30min,
and the supernatant was taken as affinity-purified antiserum. Alternatively, the
filter was treated with 0.1 M glycine (pH=2.5) for 3min and immediately
neutralized with one tenth of the volume 1M Tris (pH=8.0).
Both methods yielded highly purified antibodies which were stored in
20% glycerol at 4˚C or frozen at -20˚C.
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Antibody Origin Type Dil.
Immunoblotting
Dil. Im.
Fluores./em
Reference
mAb414 mouse monoclonal 1:2000 1:1000
Davis and Blobel,
1987
mA 9E10 (a-C-
myc)
mouse monoclonal - 1:80 SantaCruzAntibodies
a-Nup96 rabbit polyclonal 1:250 1:100 this thesis
a-Nup96/p87 rabbit polyclonal 1:250 1:200 Fontoura et al., 1999
a-Nup98 rabbit polyclonal 1:400 1:200 Radu et al, 1995
a-Nup358 rabbit polyclonal 1:1500 1:1000 Wu et al., 1995
a-Sec13 rabbit polyclonal 1:250 1:100 this thesis
a-RanGAP (19C7) mouse monoclonal - 1:250 Zymed
a-IRF9 rabbit polyclonal 1:1000 - Veals et al., 1992
a-mouseIgG FITC
conj.
donkey polyclonal - 1:100 Jackson ImmunoRes.
a-mouseIgG CY3
conj.
donkey polyclonal - 1:100 Jackson ImmunoRes.
a-rabbitIgG FITC
conj.
donkey polyclonal - 1:100 Jackson ImmunoRes.
a-rabbitIgG CY3
conj.
donkey polyclonal - 1:100 Jackson ImmunoRes.
a-mouseIgG 5nm
gold conj.
goat polyclonal - 1:250 Amersham
a-mouseIgG 10nm
gold conj.
goat polyclonal - 1:250 Amersham
a-rabbitIgG 5nm
gold conj.
goat polyclonal - 1:250 Amersham
a-rabbitIgG 10nm
gold conj.
goat polyclonal - 1:250 Amersham
a-mouseIgG HRP
conj.
donkey polyclonal 1:10000 - Amersham
a-rabbitIgG HRP
conj.
sheep polyclonal 1:10000 - Amersham
Table 2: List of the antibodies used in this thesis.
7.2.5. Reporter Gene Assays
For reporter gene assays, 293T cells grown on 100 mm dishes were co-
transfected with plasmids encoding the luciferase reporter (pCMV-Luc, 1mg),
b-galactosidase (pbgal-control (CLONTECH) 4mg), with or without with
EGFP-M-protein (pEGFPN3-M-protein, 4 mg), with or without the Nup98-
Nup96 precursor (pAlterMaxNup98/Nup96, 4mg) using the calcium phosphate
method. Therefore, 450 ml of sterile H20 was mixed with the DNA, and 50 µl
of 2.5 M CaCl2 were added. Then 500 ml of 2 x HebS (for 1 l: 16.4 g NaCl,
11.9 g HEPES acid,0.2 g Na2HPO4, 800 ml H2O, titrate to pH=7.05 with 5 N
NaOH) was added dropwise under careful vortexing and the mix was
incubated for 30 min at room temperature. The resulting DNA precipitates
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were added to the cells dropwise and fresh medium was added 5 h after
transfection.
18 h after transfection cells were lysed and luciferase and b-
galactosidase activities were measured using commercially available kits
(CLONTECH and TROPIX) according to the manufacturers’ instructions.
Cells were washed three times with ice-cold PBS, harvested in 1 ml PBS, and
after pelleting (2000 x g, 3 min, 4ºC), lysed in 100 ml luciferase lysis buffer
(CLONTECH). The lysate was incubated on ice for 15 min. Then, the cell
debris were pelleted by centrifugation in a cooled tabletop centrifuge (13000
rpm, 15 min). The supernatants could be used directly for luciferase assays
and b galactosidase assays using the reagents from the assay kits as described
by the companies. Chemiluminiscence was measured for 5 sec in a
luminometer (BIORAD), and Excel (MICROSOFT) was used to analyze the
raw data.
7.3. Cell Biology
7.3.1. Cell Culture, Transfection, and Cytokine Treatment
HeLa cells (purchased from ATCC), and mouse embryo fibroblast
wildtype and STAT-/- cells (kindly provided by David Levy, New York
Univeristy, School of Medicine) were grown in DMEM supplemented with
10% fetal calf serum, 10 U/ml penicillin, and 10 U/ml streptomycin (all
purchased from GIBCO BRL) in a cell culture incubator at 37ºC with 5%
CO2. U937 cells (ATCC) were grown in RPMI-1640 medium (GIBCO BRL)
supplemented as described above under similar conditions. For maintenance,
cells were split every 4 days in a 1/10 ratio. Cell growth was monitored with
an inverted microscope (ZEISS). For storage, cells were frozen slowly in their
appropriate medium containing 10% DMSO and were kept in cryotubes
(NUNC) at –250°C. For re-cultivation, cells were thawed quickly in a 37°C
water-bath and washed once with DMEM containing 10% FBS before
growing them on 10cm plates.
 For transfections and immunofluorescence, HeLa cells were grown on
coverslips (CORNING, thickness 1.5) placed on 35 mm dishes and were
transfected using Effectene (QIAGEN) or Lipofectamine 2000
(INVITROGEN) following the manufacturers’ instructions. After 24 h, cells
were assayed for immunoflurescence studies. For live cell imaging, HeLa
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cells were grown and transfected with Effectene on LabTek II-chambered
coverslips (NALGENE). The medium was changed 1 h before the assays and
cells were incubated at 37ºC in HEPES buffered, CO2-independent 199
medium (GIBCO BRL).
Unless otherwise stated, induction with IFN a  (ACCURATE
BIOLOGICALS) was performed with 500 antiviral U/ml and induction with
IFN g (PHARMINGEN) was performed with 100 U/ml. Treatment with TNF
a  (ACCURATE BIOLOGICALS) was performed with 50 ng/ml.
Cycloheximide and actinomycin D were used at a final concentration of 50
mg/ml and 5 mg/ml, respectively. Upon co-treatment with IFN these drugs
were added 10 min prior to the addition of IFN and were then present
throughout the induction period. Treatment with leptomycin B was at a final
concentration of 0.1 mg/ml 4 h prior to the final analysis.
7.3.2. In Situ Hybridization of poly(A) RNAs
Mouse embryo fibroblast cells were grown on 35 mm dishes
containing coverslips and transfected with 0.25 mg EGFP tagged M protein
(pEGFPN3-M-protein, kindly provided by E. Izaurralde, EMBL, von Kobbe
et al., 2001). Transfection was carried out with the non-liposomal lipid
Lipofectamine 2000 (INVITROGEN) according to the manufacturor’s
manual. IFN g treatment (500 U/ml) started 6 h after transfection and
continued for 12 h. Then, cells were fixed for 8 min at room temperature in
4% formaldehyde/PBS. After three washes with sterile PBS for 15 min each,
the cells were permeabilized in PBS containing 0.5% Triton X-100 for 5 min
at room temperature. The cells were washed again three times in PBS for 15
min. Then, cells were equilibrated in 2 x SSC for 10 min at 42ºC. The
coverslips were inverted onto 100 ml of the hybridization mix and incubated
overnight at 42ºC in a humidified chamber. The hybridization mix consisted
of 2 x SSC containing 1 mg/ml tRNA (SIGMA), 10% dextran sulfate
(PHARMACIA), 25% formamide (GIBCO BRL) and 50 mg/ml biotin-oligo
dT(45) (synthesized by the Rockefeller University Protein and DNA Resource
Center). After hybridization, the cells were washed twice with 2 x SSC and
once with 0.5 x SSC for 15 min at 42ºC. The cells were then re-fixed as
described above. After three washes with PBS at room temperature for 15 min
to remove the fixative, the cells were incubated for 30 min at room
temperature with CY3-streptavidine (diluted 1:500, SIGMA). Unbound
fluorescent probes were removed with three washes in PBS/0.2 % Triton X-
100 and two washes in PBS. The coverslips were mounted in Prolong antifade
reagent (MOLECULAR PROBES). The presence or absence of poly(A) RNA
in the cytoplasm was scored in fifty EGFP-M-protein transfected cells in a
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Leica TC SP spectral confocal microscope. Cells that were rounded due to the
cytopathic effect of the overexpressed VSV M protein (reference) were not
scored.
7.3.3. Immunofluorescence and Confocal Microscopy
HeLa cells or mouse embryo fibroblasts were grown on coverslips in
35 mm dishes, and were used for indirect immunofluorescence after removing
the growth medium and performing three washes with ice-cold PBS. The
washed U937 cells were spun onto coverslips coated with poly-lysine (0.1
mg/ml in PBS) in a cytospin centrifuge at 1000 rpm for 2 min at room
temperature. As described in the results section, cells were either fixed first
and then permeabilized, or permeabilized first followed by fixation depending
on the experimental approach. Cells were washed three times with ice-cold
PBS between fixation and permeabilization. For fixation, cells were treated
with 4 % paraformaldehyde in PBS for eight minutes at room temperature, or
cells were fixed and permeabilized at once for five minutes with 100 %
methanol at –20°C. For permeabilization, cells were treated with various
detergents, such as Triton-X 100 (0.2-0.5 % in PBS), digitonin (40 µg/ml in
PBS), Tween-20 (0.2 % in PBS), NP-40 (0.2 % in PBS) or saponin (0.5 % in
PBS) for 10 minutes (saponin only) or five minutes (all the others). Then,
cells were washed three times in PBS followed by incubation with the first
antibodies (described in table 2) in PBS supplemented with 2 % BSA for 1 h
at room temperature. Then, cells were washed three times with PBS, and were
incubated with FITC-conjugated or CY3-conjugated goat a-rabbit antibodies,
and CY3-conjugated or FITC-conjugated donkey a-mouse antibodies (all
diluted 1:100 in 2 % BSA/PBS; JACKSON IMMUNO RESERACH) for 30
min at room temperature. Cells were washed three times with PBS, mounted
in ProLong antifade reagent (MOLECULAR PROBES) and analyzed with a
Leica TCS SP spectral confocal microscope or with a ZEISS LSM510
confocal microscope. Image processing was performed with Photoshop 7.0
(Adobe).
7.3.4. Fluorescence Recovery after Photobleaching (FRAP) and
Fluorescence Loss in Photobleaching (FLIP)
Experiments were performed on a Zeiss LSM510 confocal microscope
equipped with an air stream incubator (NEFTEK) as previously described
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(reference). Cells were transfected with EGFP, Sec13-EGFP or co-transfected
with Sec13-EGFP and truncation mutants of Nup96 using Effectene
(QIAGEN). Before imaging the medium was changed to CO2 independent
199 Medium (GIBCO BRL) and cells were allowed to equilibrate for at least
1 h. Transfected cells with low expression levels were selected for the
experiments and monitored with a 488-nm Kr/Ar laser line at 75% laser power
and 2% transmission (imaging intensity). For FRAP analyses, eight imaging
scans of the area of interest were performed, and then a specific region was
selected for bleaching. Twenty bleaching iterations were performed with 75 %
laser power and 100 % transmittance. Then, scans were taken every 15 s or 45
s during the course of fluorescence recovery until the fluorescence intensity
reached a plateau. FRAP recovery curves were generated from background
subtracted images, and fluorescence was normalized by measuring the
fluorescence intensity of an unbleached, transfected, adjacent cell. The
normalized fluorescence was determined for each image and compared with
the initial normalized fluorescence to determine the amount of signal lost
during the bleach pulse and during imaging. The equation used for these
calculations has been previously described (Griffis et al., 2002). The
normalized fluorescence intensity was determined by Inorm=T0•It/Tt•I0, where
Inorm is the normalized fluorescence intensity, T0 is the fluorescence intensity
of the total cell before photobleaching, I0 is the fluorescence intensity of the
bleaching area before the bleach, Tt is the fluorescence intensity of the total
cell at time t after photobleaching, and It is the fluorescence intensity of the
bleached area at time t.
FLIP experiments were performed by bleaching an ER region of cells
expressing Sec13-EGFP or PML-EGFP every 4 min followed by imagining
scans every 30 s to monitor recovery. In the case of EGFP alone bleaching
was performed every 30 s. This procedure was repeated until the nuclear
fluorescence was significantly reduced. The selected areas chosen in Fig. 19
were bleached 10 times which resulted in reduction of the nuclear
fluorescence by approximately 80%. For plotting the data, measurements were
normalized as described for the FRAP experiments. All FRAP and FLIP
experiments were repeated five times. For quantification, three experiments
were analyzed using the LSM510 software package and Excel. Videos of the
experiments are added as supplements.
7.3.5. Immuno Electron Microscopy of Nuclear Envelopes
Isolated NE were fixed for 15 min in 2.5% formaldehyde in low
sucrose solution B (see previous paragraph) and pelleted at 2000 x g for 5 min
onto 35-mm plastic dishes. Subsequent antibody incubations and washes were
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performed in the dishes with PBS supplemented with 1% BSA. Attached NEs
were washed three times, samples were incubated with primary antibodies
(see table for dilutions) for 1 h. Following three washes, bound antibodies
were detected with goat anti–rabbit IgG conjugated with 10-nm gold, or goat
anti–mouse IgG conjugated with 5-nm gold (AMERSHAM). Unbound
antibodies were removed by additional washes.
Then, cells were immersed in Karnvovsky’s fixative (5%
glutaraldehyde, 4% formaldehyde in 80mM PBS) containing 0.6 M sorbitol
for 12h at 4°C. After postfixation in OsO4 for 1 h at 4°C, specimens were
dehydrated in graded series of ethanol, transferred to propylene oxide, and
embedded in Epon. Thin sections (40-60 nm) were prepared, mounted on
carbon-coated grid and stained with uranyl acetate and lead citrate.
Transmission electron microscopy (TEM) was performed on a JOEL 100X
electron microscope at 40000 times magnification (80 kV). Pictures were
developed on P4 films (KODAK).
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8. Results
8.1. Overview
In this study the two major nucleoporins Nup98 and Nup96 were
characterized with a focus on their localization and regulation. Furthermore,
Sec13 was identified as a binding partner of Nup96, and the dynamics of this
new constituent of the NPC was investigated.
Part A of this thesis deals with the localization of Nup98 and Nup96.
Indirect immunofluorescence followed by confocal microscopy and immuno
electron microscopy with established and newly developed antibodies was
used to clarify the Nup98 and Nup96 localization at the NPC. Part B shows
the specific IFN dependent gene regulation of Nup98 and Nup96, and their
potential role in antiviral response. In part C, Sec13 has been identified as
direct binding partner of Nup96. The localization of Sec13 at the NPC was
analyzed, and studies of Sec13 dynamics revealed the presence of distinct
pools of Sec13. Finally, targeting studies demonstrated the presence of a NLS
at the WD repeat region of Sec13.
8.2. Part A: The Expression and Localization of Nup98 and Nup96
8.2.1. Differential Expression of the Nup98/Nup96 gene in Human
Tissues
Nup98 and Nup96 are derived from several mRNAs via alternative
splicing. It is likely that additional alternatively spliced variants will still be
discovered and thereby increasing the number of known Nup98/Nup96
isoforms. Previous experiments have demonstrated that the full length
Nup98/Nup96 mRNA is the most abundant in HeLa cells and rat liver as
compared to the abundance of smaller alternatively spliced products described
in the introduction (Fontoura et al, 1999). It has not been investigated so far
the differential expression of the Nup98/Nup96 gene in various human tissues.
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Figure 6. Nup98-Nup96 mRNA is differentially expressed in human tissues.
Hybridization was performed with a [32P]-dCTP labeled probe against the Nup98-
Nup96 mRNA on MTN-blots (CLONTECH). The differential intensities of the bands
reflect the expression levels of the Nup98-Nup96 gene. The Nup98-Nup96 mRNA
has approximately 7.5 kb and 9.5 kb. Note the abundance of a smaller isoform in
various tissues such as placenta, skeletal muscle and kidney. The blots were
normalized with b-actin.
To address this issue and to identify hypothetical new Nup98/Nup96
isoforms, hybridization experiments were performed on MTN blots (multiple
tissue northern blots) with a probe specific to the Nup98/Nup96 mRNA. In
addition, a probe specific to b-tubulin was used to monitor the equal loading
of mRNAs in the tested tissues. The Nup96 probe was prepared by amplifying
and labeling a sequence corresponding to the amino acids 1485 to 1560 of the
Nup96 protein, which represent part of its C-terminal region. By performing a
nBLAST (Altschul et al, 1990, Gish and States, 1993) search, cross-reactivity
of this probe with other sequences was excluded.
Figure 6 shows that Nup96 mRNA is distributed differently in the human
body. The amount of Nup96 mRNA varies up to a factor of 20. The highest
levels were found in testis followed by skeletal muscle and placenta. In
contrast, only a small amount of Nup96 mRNA was found in peripheral blood
leukocytes and in the intestines. The major band, detected at about 7500 bp,
corresponds to the predicted mRNA size of Nup98/Nup96, calculated from
the published sequence (accession: AF071076). Interestingly, in some tissues
like in kidney or placenta, an additional band was detected at about 7.2kb
indicating the abundance of additional Nup98/Nup96 isoforms which have not
been characterized yet and will be analyzed in future studies. Notably, the
transcripts differing in less than 300 bp cannot be resolved with these MTN
blots making it impossible to distinguish the Nup96 isoform from the p87
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isoform. This will be addressed in later sections of this study (RT-PCR
analysis upon interferon treatment).
Similar northern blot analyses of other nucleoporins have yielded a
compatible picture of their differential gene expression in various tissues
(Zhang et al., 1999). Assuming an identical stoichiometry of NPCs this data
demonstrates a tissue-dependent differential distribution of NPCs.
8.2.2. The intracellular Localization of Nup98
Nup98 has been previously localized to the nucleoplasmic side of the NPC
(Radu et al., 1995). This localization and its role in nuclear import of proteins
led to the hypothesis that this nucleoporin might be involved in the
directionality of transport events (Radu et al., 1995, Ben-Efraim and Gerace,
2001). These assumptions were supported by in-vitro-affinity studies of
transport-complexes with various nucleoporins (Ben-Efraim and Gerace,
2001). New evidence contradicted this unsymmetrical localization of Nup98:
First, the yeast homologue of Nup98, N-Nup145 was localized to the
cytoplasmic and the nucleoplasmic sides of the NPC (Rout et al., 2000).
Secondly, several research groups hypothesized a shuttling activity of Nup98,
localizing it to the cytoplasmic side of the NE (Zolotukhin and Felber, 1999,
Griffis et al., 2002 and 2003).
Therefore, we re-investigated the intracellular distribution of Nup98 in
HeLa cells and in rat liver nuclei. We affinity purified antibodies against the
C-terminus of Nup98 (amino acid 519 to 869), which does not contain any FG
repeats. As shown by immunoblot analysis in Fig. 7 A, the affinity purified
antibodies raised against the carboxyl terminal region of Nup98 specifically
recognized Nup98 in HeLa cells lysates.
We then carried out double-immunofluorescence and confocal microscopy
on HeLa cells using our anti-Nup98 antibodies. Since we were particularly
interested in the localization of Nup98 at the NE, we permeabilized HeLa
cells with TritonX-100 or with digitonin. TritonX-100 permeabilizes all
cellular membranes, however, digitonin permeabilizes the plasma membrane
leaving the NE intact at low concentrations. The upper panel of Fig.7B
demonstrates that Nup98 localized at the NE and diffusely intranuclear after
TritonX-100 permeabilization. Nup98 co-localized with other Nups that are
recognized by the monoclonal antibody mAb414. The lower panel of Fig.7B
showed a staining of the NE with anti-Nup98 antibodies in cells
permeabilized with digitonin. In these cells, anti-Nup98 antibodies did not
have access to the nucleoplasmic side of the NPC indicating abundance of
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Figure 7. Immunolocalization of Nup98 to both sides of the NPC and intranuclear
sites. (A) Immunoblot analysis of HeLa cell lysates performed with anti-Nup98
antibodies and probed with either pre-immune serum (control) or with antibodies
against the C-terminus of Nup98. (B) Immunofluorescence and confocal microscopy
of HeLa cells, which were fixed, permeabilized with Triton-X100 or digitonin, and
labeled with anti-Nup98 antibodies and mAb414 (labels some FG-repeat containing
Nups). (C) Isolated rat liver nuclear envelopes were probed with rabbit anti-Nup98
antibodies and mouse anti-RanGAP1 mAb 19C7. Rabbit and mouse antibodies were
detected with 10 nm and 5 nm gold-coupled secondary antibodies, respectively.
Envelopes were processed for thin sectioning and observed by electron microscopy.
Nup98 epitopes on the cytoplasmic side of the NPC. Again, Nup98 co-
localized with other Nups that are recognized by mAb414. However, the rim-
staining of Nup98 was much weaker than in the cells which were treated with
TritonX-100 indicating that either the majority of Nup98 was localized on the
nucleoplasmic side of the nuclear envelope, or that the Nup98 epitopes are
better exposed on the nucleoplasmic side.
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We further investigated the localization of Nup98 at the NPC by double-
immunoelectron microscopy using affinity purified anti-Nup98 antibodies.
This was carried out on isolated nuclear envelopes from rat liver (see
materials and methods for details). As shown in Fig. 7C, Nup98 which was
detected with secondary 5 nm gold-labeled antibodies, localized at both the
nucleoplasmic and cytoplasmic sides of the NPC. In contrast, RanGAP1,
detected with 10 nm gold labeled antibodies, was localized exclusively to the
cytoplasmic side of the NPC. The initial ultrastructural studies on the
localization of Nup98 at the nuclear envelope have been performed by
cryosectioning of cells which were then labeled with anti-Nup98 antibodies
(Radu et al., 1995). This procedure might not favor epitope exposure.
Therefore, by using isolated NE we were able to localize Nup98 at the
cytoplasmic as well as at the nucleoplasmic side of the NPC. Furthermore, the
NEs for the immunolocalization of Nup98 were prepared in the absence of
detergents which prevented the loss of proteins.
8.2.3. The intracellular Localization of Nup96 and its Isoforms
Previous studies have localized Nup96 exclusively to the nucleoplasmic
side of the NPC and to additional intranuclear sites (Fontoura et al., 1999).
Here, we re-investigated the intracellular localization of Nup96 during
interphase, since Nup98 had been shown to bind to Nup96 (Fontoura et al.,
2001), and we have described the localization of Nup98 to both sides of the
NPC. Furthermore, Nup96 has been identified as a constituent of the Nup107-
160 subcomplex (Fontoura et al., 1999, Belgareh et al., 2001, Vasu et al.,
2001). Several members of this subcomplex have been localized to both sides
of the NPC (Belgareh et al., 2001) making it likely that all their constituents
including Nup96 are found on the nucleoplasmic and cytoplasmic side of the
NPC.
Therefore, we have performed immunofluorescence and confocal microscopy
with antibodies that can differentially recognize the protein products of
alternatively spliced forms of the Nup96 gene. The different isoforms have
been described in the introduction. For our studies, antibodies have been
raised against a region of Nup96 (amino acids 1291-1482) which also
recognize a smaller alternatively spliced isoform denominated p87 (Fontoura
et al., 1999). The p87 isoform had been found expressed under certain cell
physiological circumstances depending on cell confluency or levels of
interferons (our own observation and Enninga et al., 2002). Thus, to raise
antibodies which would specifically recognize Nup96, a 9 kDa region of the
C-terminus of Nup96 (amino acids 1485-1559) was fused to glutathione-S-
transferase and was expressed in E. coli (see materials and methods for
Jost Enninga- Nup98 and Nup96                                                                                     44
Figure 8. Immunolocalization of the Nup96 isoforms to both sides of the NPC and
intranuclear sites. (A) Immunoblot analysis of cell extracts obtained from U937 cells
performed with pre-immune serum (control), anti-Nup96 antibodies or anti-
Nup96/p87 antibodies. (B) Differential recognition of Nup96 and p87 by the anti-
Nup96 and anti-Nup96/p87 antibodies. The anti-Nup96 antibodies were developed
against the 9 kD polypeptide region which is unique to the Nup96 isoform (amino
acids 1485-1559) and the anti-Nup96/p87 antibodies were developed against a region
which is common to Nup96 and p87 (amino acids 1291-1482). Nup96 and p87 were
in vitro transcribed and translated in a reticulocyte lysate system and
immunoprecipitated with the indicated antibodies to determine specificity. (C)
Immunoblot analysis of cell extracts obtained from U937 cells which were treated
with IFNg for 12 h. The protein amounts of Nup96 increase after interferon treatment
and the Nup96/p87 antibodies reveal the induction of the p87 isoform after IFNg
treatment. (D) Nup96 is localized at the NPC, intranuclear sites and nucleolus. (a-f)
U937 cells were first fixed with formaldehyde, permeabilized with Triton X-100 and
immunolabeled with anti-Nup96 and mAb414 antibodies (a-c) or anti-Nup96 and
anti-nucleolin antibodies (d-f). (g-i) U937 cells were treated with Triton X-100 prior
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to fixation and labeled with anti-Nup96 and mAb414 antibodies. (E)
Immunolocalization of Nup96 to both cytoplasmic and nucleoplasmic sides of the
NPC. Isolated rat liver nuclear envelopes were probed with rabbit anti-Nup96/p87 or
anti-Nup96 antibodies and mouse anti-RanGAP1 mAb 19C7. Rabbit and mouse
antibodies were detected with 10 nm and 5 nm gold-coupled secondary antibodies,
respectively. Envelopes were processed for thin sectioning and observed by electron
microscopy. C, cytoplasmic side. N, nucleoplasmic side.
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details about the production of these antibodies). The purified recombinant
protein was injected into rabbits and polyclonal antiserum was used for
affinity purification of highly specific antibodies.
By using both anti-Nup96 and anti-Nup96/p87 antibodies in immunoblot
analysis, we showed here that in U937 cells not treated with IFNg, only the
Nup96 isoform was detected (Fig. 8A). To demonstrate specificity of both
antibodies to these different isoforms, we performed in vitro expression of
Nup96 and p87 labeled with 35S-methionine followed by immunoprecipitation
of both proteins with anti-Nup96 and anti-Nup96/p87 antibodies (Fig. 8B).
The anti-Nup96/p87 antibodies immunoprecipitated both Nup96 and p87
isoforms (Fig. 8B). In contrast, the anti-Nup96 antibodies immunoprecipitated
exclusively the Nup96 isoform (Fig. 8B). The p87 isoform could not be
immunoprecipitated with the anti-Nup96 antibodies, and was only found in
the unbound fraction. The fast migrating bands obtained during in vitro
translation represent most probably protein products resulting from
downstream initiation of translation. We also looked at the protein amounts of
Nup96 and p87 after IFNg treatment. The role of interferons on Nup98 and
Nup96 expression will be described in the following section of this study.
Immunoblot analysis of U937 cell extracts with anti-Nup96 and anti-
Nup96/p87 antibodies showed up-regulation of Nup96 protein after IFNg
treatment (Fig. 8C). Furthermore, the anti-Nup96/p87 antibodies detected the
p87 isoform in the cells treated with IFNg as shown on the right panel of
figure 8C.
Immunolocalization studies previously performed with the Nup96/p87
antibodies showed labeling at the nuclear rim and intranuclear sites (Fontoura
et al., 1999). In the absence of IFN, these cells expressed only the Nup96
isoform indicating that the observed labeling with the Nup96/p87 antibodies
reflected the intracellular localization of Nup96. We show here labeling of
cells with anti-Nup96 antibodies, which localized Nup96 at the nucleolus in
addition to the nuclear rim and intranuclear sites (Fig. 8D a-c). Thus, both
anti-Nup96/p87 and anti-Nup96 antibodies detected Nup96 at the nuclear rim
and intranuclear sites. However, only the later labeled the nucleolus. This co-
localization was confirmed using anti-nucleolin antibodies which resulted in
an overlapping staining of Nup96 and nucleolin (Fig. 8D d-f). These results
indicate differences in epitope exposure. In addition, the nuclear rim could
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only be labeled with anti-Nup96 antibodies when cells were treated with
TritonX-100 prior to fixation, which allowed epitope exposure (Fig. 8D, g-i).
To further analyze the NPC localization of Nup96 at the ultrastructural
level, we carried out double-immunoelectron microscopy using the two anti-
Nup96 antibodies described above. As shown in Fig.8E, Nup96 localized at
both the nucleoplasmic and cytoplasmic sides of the NPC. In contrast,
RanGAP1 was localized exclusively to the cytoplasmic side of the NPC.
Previous studies reported the localization of Nup96 at the nucleoplasmic side
of the NPC using the anti-Nup96/p87 antibodies on nuclear envelopes
prepared in the presence of heparin (Fontoura et al., 1999). Here, we did not
use heparin in the preparation of the nuclear envelopes (see materials and
methods), since we have observed that heparin used in the preparation can
dissociate some Nups from the NPC (unpublished observation), indicating that
the association of Nup96 with the cytoplasmic side of the NPC is sensitive to
heparin treatment as opposed to its association with the nucleoplamic side
which was clearly resistant to heparin treatment (Fontoura et al., 1999). Thus,
Nup96 localized at the nucleoplasmic and cytoplasmic sides of the NPC.
8.3. Part B: A possible Role of Nucleoporins in an antiviral
Response
Interferons are cytokines that play a key role in antiviral defense,
growth inhibition, apoptosis and the general immune response (reviewed in
Stark et al, 1998). They are grouped in type I interferons (interferon a ,
interferon b, interferon w and interferon t) and type II interferons (interferon
g) based on their structural homology and the cell type in which they are
synthesized. Type I IFNs can be produced by a variety of cell types, however,
IFNg is only produced by lymphatic cells. All cells expressing interferon
receptors can potentially respond to interferon stimulation (Farrar and
Schreiber, 1993).
The genes regulated by interferon usually carry distinct promoter
sequences that are recognized by interferon activated transcription factors.
These sequences are named interferon signaling responsive elements (ISRE)
and g-IFN activated sequences (GAS).
Identification of Nup96 from a cDNA library (Fontoura et al., 1999)
revealed its identity to the COOH-terminal sequence of a partial clone that
was specifically induced by IFN g (Yang et al., 1995). Furthermore, the two
classical elements, GAS and ISRE, that mediate increased gene expression by
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IFNs were found in the promoter/enhancer regions of the Nup98/Nup96 gene
(our own observation). Therefore, we investigated the regulation of the
Nup98-Nup96 gene by IFN.
8.3.1. Nup98 and Nup96 are up-regulated by interferons
When U937 cells were incubated with IFNg for up to 12 hours, we
observed a significant increase in mRNA levels by semiquantitative RT-PCR
of whole poly(A) mRNAs from U937 cells (Fig. 9A). This induction was not
dependent on ongoing protein synthesis, because it was not inhibited by the
addition of cycloheximide as indicated in the figure (Fig. 9A). These findings
suggest transcription regulation of the Nup98/Nup96 gene independent of any
IFN responsive factors, although other regulatory mechanisms cannot be
excluded. Interestingly, the alternatively spliced isoform p87 was specifically
up-regulated by IFN g. In this case, the addition of cycloheximide inhibited
the induction of p87. This finding demonstrated that the alternative splicing of
the Nup98/Nup96 gene depended on proteins which were regulated by IFNg.
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Figure 9. Effects of IFNg, IFNa, or TNFa on the expression of Nup98, Nup96 and
other nucleoporins. (A) Levels of Nup98-Nup96 and Nup98-p87 mRNAs at various
times after IFN g-treatment in the presence or absence of cycloheximide (CHX)
investigated by semiquantitative RT-PCR. Controls (CO) were incubated for 12 h
without IFNg. b-tubulin mRNA amounts are not altered by IFN g treatment (B)
Immunoblot analysis at various times after IFNg treatment of U937 cells. Equal
amounts of protein of total cell lysates were assayed with either mAb414 or with
specific antibodies against Nup96 or Nup98. Only Nup98 and Nup96 protein
amounts are increased upon IFN g treatment (C) Immunoblot analysis of Nup96 after
IFNa or TNFa treatment. Nup96 protein amounts are up-regulated by IFN a, but not
by TNF a. (D) Immunoblot analysis with anti-IRF9 antibodies of the same total cell
lysates used in B. IRF9 protein amounts are up-regulated after IFN g treatment.
_______________________________________________________________
The increased abundance of Nup98/Nup96 mRNA in response to IFNg
was matched by increased amounts of Nup96 and Nup98 proteins. In contrast,
there was no significant increase in the amounts of other Nups using the same
cell lysates, such as p62 and Nup214 that react with the monoclonal antibody
mAb414 (Fig. 9B; also compare Fig. 11 A, left panels in upper and lower row
of images). As expected, there were increased amounts of the IFN-inducible
protein IRF9 (Fig. 9D and Bluyssen et al., 1996). Of two other cytokines
tested, only IFNa stimulated Nup96 expression, but to a lesser degree than
IFNg, whereas TNFa  had no effect (Fig. 9C). These experiments were
performed by immuno blotting of total U937 cell lysates followed by
detection with Nup96 specific antibodies.
8.3.2. STAT1 regulates Nup98 and Nup96 Expression
IFNg signals through specific intracellular pathways as illustrated in
figure 10A, and it regulates a subset of specific IFNg  responsive genes (Stark
et al., 1998). Major players in these signaling pathways are the Janus kinases
(JAKs) and the signal transducers and activators of transcription (STATs).
Together they lead to a fast response of gene expression (Schindler and
Darnell, 1995). In summary, upon binding to interferon, the IFN receptors
dimerize and recruit two JAK tyrosine kinases to their receptor. These kinases
are then able to autophosphorylate and to transphosphorylate, recruiting two
STATs to the receptor complex. STATs dimerize upon phosphorylation of
their Src-homology-domain-2 (SH2) and can then be imported into the
nucleus to bind to the specific interferon responsive elements (Sekimoto et al,
1996).
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Figure 10. Up-regulation of Nup98 and Nup96 expression by IFNg is STAT1-
dependent. (A) Schematics of the IFN signaling pathways. Details are described in
the text. (B) Immunoblot analysis of whole cell extracts of STAT1+/+ or STAT1-/-
mouse embryo fibroblasts that were incubated for the indicated time periods with
IFNg. The anti-Nup98 antibodies recognize multiple bands indicating multiple
isoforms of Nup98 in mouse embryo fibroblasts.
Type II interferon (IFNg) pathways do not need additional factors for
transcription initiation, however, in type I interferon pathways, a
heterotrimeric complex is formed between two STATs and the activating
factor p48 (John et al, 1991). Recently, it has been shown that interferons also
signal through additional pathways, e.g. the MAP-kinase pathway (see Stark
et al, 1998). Even though the main principles have been proposed, the details
of the signaling pathways need further elucidation. For example, activation of
transcription is not well understood, and there is also a plethora of additional
cellular functions that are regulated by interferon (Stark et al, 1998).
To determine whether the IFNg-stimulated expression of Nup98 and
Nup96 was mediated by STAT1, we tested STAT1-/- or STAT1+/+ mouse
embryo fibroblasts (Durbin et al., 1996) either untreated or treated with IFNg.
The embryo fibroblasts were kindly provided by Dr. David Levy from the
New York School of Medicine. Immunoblot analysis of total cell lysates of
the wild type cells showed that IFNg  increased the amounts of Nup98 and
Nup96 as shown in the first and third panel of figure 10B. The up-regulation
of Nup98 and Nup96 was similar to the results obtained in U937 cells (first
and third panel of figure 10B). In contrast, the STAT1-/- cells did not respond
to IFNg as indicated in the second and the fourth panel of figure 10B. This
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demonstrates the essential role of STAT1 in regulating Nup98 and Nup96
gene expression, however other forms of regulation cannot be ruled out. The
multiple bands of Nup98 in the first and second panel of figure 10B indicate
multiple isoforms of Nup98 in mouse embryo fibroblasts.
8.3.3. The Amounts of Nup98 and Nup96, but not their
Localization, are regulated by IFNg
Immunofluorescence microscopy was used to test whether the IFNg-
induced Nup98 and Nup96 were properly localized (Fig. 11). In figure 8 it
was demonstrated that Nups recognized by mAb414 were not regulated by
interferons. Therefore, the fluorescence intensity of mAb414 in treated or
untreated cells with IFNg was used as internal control to normalize the
fluorescence signals in these specimens for Nup98 and Nup96
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Figure 11. Double immunofluorescence localization of Nup98, of Nup96 and of
largely nuclear rim-restricted Nups in U937 cells that were not treated (upper panel A
and B) or treated with INF g for 12 hours (lower panel A and B). U937 cells were
fixed, permeabilized, and incubated with anti-Nup98 (A) or with anti-Nup96
antibodies (B) (red, nuclear rim and nuclear interior) and mAb414 antibody (green,
primarily nuclear rim). Note, that the intensity of the mAb414 labeling did not
change upon INF g treatment; this is in contrast to the considerable increase in the
anti-Nup98 and Nup96 staining after IFNg treatment. The ratios of mAb414/Nup98
and mAb414/Nup96 intensities in the equatorial plane of the nucleus were quantified
using the Leica TCS spectral confocal microscope software as shown in the right
panels.
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The IFNg-stimulated expression of Nup98 (Fig. 11A) and of Nup96
(Fig. 11B) yielded an enhanced staining of these proteins at their
physiological sites, the nuclear pore complexes and the nuclear interior. At the
right side of the figure fluorescence intensities were quantified as described
above. The x-axis reflects the nuclear diameter of the measured cells. Thus,
both intranuclear and NPC-associated Nup98 and Nup96 may be involved in
IFNg-mediated responses.
8.3.4. IFNg Treatment or increased Amounts of Nup98 and Nup96
reverse an mRNA Export Blockage caused by the VSV M Protein
VSV replicates in the cytoplasm (Fields et al., 1996), and VSV M
protein inhibits nuclear export of host cell mRNA, rRNA and snRNAs  (Her
and Dahlberg, 1997) as a mechanism to shut off host cell gene expression. As
mentioned in the introduction, it has been proposed that an interaction of the
M protein with Nup98 is the cause of the mRNA nuclear export inhibition
(von Kobbe et al., 2000). We analyzed whether Nup98 and the M protein were
co-localized in mouse embryo fibroblasts by transfecting GFP-M-protein
(kindly provided by Dr. Elisa Izaurralde, EMBL, Heidelberg) and performing
indirect immuno fluorescence with a-Nup98 antibodies. As illustrated in
figure 12, the GFP-tagged M protein exhibited a nuclear rim staining in
addition to staining of other intracellular sites. The VSV M protein co-
localized with Nup98 as demonstrated in the merged panel.
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Figure 12. Co-localization of Nup98 with the VSV M protein at the nuclear
envelope. Mouse embryo fibroblasts were transfected with EGFP-tagged M protein
(green) and labeled with anti-Nup98 antibodies (red) for immunofluorescence
confocal microscopy. A confocal section in the equatorial plane is shown.
Then, we tested whether increased expression of Nup98 and Nup96 by
IFNg would reverse this inhibition and restore nuclear export of host cell
mRNA. Mouse embryo fibroblasts transfected with a cDNA coding for a
GFP-tagged M protein were incubated in the absence or presence of IFNg.
The cellular localization of poly(A) containing mRNA was then assessed by
in situ hybridization with oligo(dT) (Fig. 13A). In the absence of IFNg, most
of the mRNA was localized in the nucleus of the M protein-transfected cells
(upper panel). In contrast, IFNg treatment of M protein-transfected cells
yielded an even distribution of mRNA between the nucleus and the cytoplasm
(Fig. 13B). Thus, IFNg treatment indeed reverses the M protein-mediated
inhibition of host cell mRNA export.
IFNg induces the expression of a wide variety of genes, many of which
are involved in antiviral response (Boehm et al., 1997). To determine whether
induction of Nup98 and Nup96 was sufficient to reverse the M-protein export
block, we tested whether transfection with Nup98 and Nup96 cDNA would
substitute for IFNg and relieve the inhibition of mRNA export. Using a
luciferase reporter gene assay as described in the materials and methods
section, cells were co-transfected with a mixture of plasmids coding for the M
protein alone, for Nup98 and Nup96 alone or for both. M protein expression
clearly inhibited luciferase expression and this inhibition was partially
relieved by Nup98 and Nup96 expression (Fig. 13C). Thus, Nup98 and Nup96
expression is capable of reversing M protein-mediated inhibition of nuclear
mRNA export.
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Figure 13. IFN g or Nup98-Nup96 cDNA can revert the M protein-mediated
inhibition of nuclear mRNA export. (A) STAT1+/+ mouse embryo fibroblasts were
transfected with a plasmid encoding the EGFP-M-protein and either not incubated
(upper panel) or incubated with IFNg (lower panel). Oligo-dT in situ hybridization
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and fluorescence confocal microscopy were performed as described in the Materials
and Methods section. In the M protein transfected cell that was not treated with IFN
g, the oligo-dT reactive mRNA remained largely in the nucleus (upper panel)
whereas IFN g treatment of an M protein-transfected cell yielded a nucleo-
cytoplasmic distribution of mRNA that resembled that of an adjacent cell that was
not transfected by the M protein (lower panel). (B) STAT1+/+ or STAT1-/- cells
were transfected with M protein, incubated in the absence or presence of INF g,  and
the percentage of cells that retained their mRNA in the nucleus was determined (C)
In a luciferase reporter gene expression assay, 293T cells were cotransfected with
empty vector, EGFP-M-protein, the Nup98-Nup96 cDNAs or both, as indicated.
Luciferase activity was assayed. Co-transfection of the Nup98-Nup96 cDNA reverts
the inhibition of reporter gene expression mediated by the M protein. See text for a
detailed description.
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8.4. Part C: Identification of new binding partners of Nup96
In the previous chapter we have analyzed the behavior of Nup98 and
Nup96 under certain cell physiological circumstances such as IFNg treatment.
From these experiments we were able to deduce possible functions of these
proteins in anti-viral response. Another approach to search for hypothetical
functions of proteins is through searching for their direct interactors. In yeast,
comprehensive protein-protein interaction maps have been established
(reviewed in Drewes and Bouwmeester, 2003). Taken into consideration that
binding partners are functionally correlated, the function of a protein can be
analyzed through its direct binding partners.
8.4.1. Specific interaction of Sec13 with an amino-terminal Region
of Nup96
To identify Nup96-interacting partners, we have used both genetic and
biochemical approaches. Based on the predicted secondary structure of Nup96
determined by the PHD program (Combet et al., 2000), we have chosen an
amino terminal region of Nup96 (amino acids 1-378) as bait to perform yeast
two-hybrid screenings. Yeast expressing the GAL4 DNA-binding domain
fused with the amino terminal region of Nup96 were mated with yeast
expressing GAL4 activation domain:library protein fusions. Three different
libraries derived from B-cells, breast and placenta were used. Upon protein-
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Figure 14. Interaction of Sec13 with an amino terminal region of Nup96 in yeast
two-hybrid screenings performed with multiple libraries and in in vitro binding
assays. (A) b-galactosidase assays demonstrate interaction between Sec13 cDNAs
(Sec13_12, Sec13_13, Sec13_20, Sec13_21, and Sec13_28) isolated independently
in yeast two-hybrid screenings and Nup96 (amino acids 1-378) as bait. Baits include
the empty vector (pBUTE) and the following proteins cloned in-frame with the
GAL4 DNA binding domain: Nup96 N-terminus (amino acids 1-378), the EF-hand
domain of intersectin (INT EH), the coiled-coiled domain of intersectin (INT COIL)
and the human SKP1 homologue (F19). Preys include the empty prey (activation
domain) vector (pGADC1), Sec13 cDNAs isolated independently from different
screenings, mouse epsin and human Fbox5. b-gal activity was assayed in cultures
expressing the bait and prey following mating and selection in interaction selection
media. Purple indicates a positive signal; yellow is negative. (B) Table shows baits
and preys as in A. Growth was measured by OD620 readings 48 h after dilution of
mating mixtures into interaction selection media. (C). b-galactosidase readings from
A. High OD numbers marked in yellow represent positive interactions. (D and E)
Wild-type Nup98, Nup96, and truncated mutants of Nup96 were transcribed and
translated in vitro in the presence of [35S]methionine and incubated with immobilized
recombinant GST-Sec13 (1 mg) as described in Materials and Methods. Bound and
unbound fractions were analyzed by SDS-PAGE and autoradiography. (F) Schematic
representation of the wild-type and truncated mutants of Nup96. Shown in red is the
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6 kD region that is present in all isoforms of the Nup98-Nup96 gene. Shown in
purple is the 9 kD region unique to the Nup96 isoform. (G) Wild-type Nup96 and
truncated mutants of Nup96 were transcribed and translated in vitro in the presence
of [35S]methionine and incubated with 1 mg of immobilized recombinant GST-Sec13
mutants (amino acids 1-302; and 301-322) as described in Materials and Methods.
Bound and unbound fractions were analyzed by SDS-PAGE and autoradiography.
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protein interaction, reporter genes (HIS, ADE and LACZ) were transcribed.
Interactors were selected via growth on yeast dropout media and confirmed
via assaying for ß-galactosidase activity. Plasmids encoding putative
interactors were isolated from yeast, analyzed by restriction digest and re-
assessed for interaction against an array of target and non-target bait
constructs. This validation step helps to eliminate false positives that arise in a
yeast two-hybrid screening. Approximately fifty million clones were screened
via mating. Of these, 6 yeast clones were tested positive for interaction via
selection on histidine drop-out medium and b-gal assay. Plasmids were
isolated and analyzed via restriction digest. From these 6 colonies tested, five
clones listed in figure 14 A-C grew in interaction selection media and were b-
gal positive in the validation test, and therefore, were strong interactors. These
clones were subsequently identified via sequencing as Sec13 (Sec13R).
To confirm our findings obtained with the yeast two-hybrid screenings, we
performed in vitro binding studies using recombinantly expressed Sec13 and
in vitro expressed full length Nup96, Nup98 and deletion mutants of Nup96.
As shown in Fig.14D, full length Nup96 interacted with Sec13, as opposed to
Nup98, which did not show any significant interaction with Sec13. To map
the Sec13 binding site on Nup96, we have generated truncated mutants of
Nup96 and performed again in vitro binding assays (Fig 14E and 14F). The
amino terminal region of Nup96 (amino acids 1-427), which contains the
sequence used as bait in the yeast two-hybrid screening, interacted with
Sec13. In contrast, the carboxyl terminal region of Nup96 (amino acids 428-
849) did not bind Sec13. By generating additional mutants of the amino
terminal region of Nup96 and based on the yeast two-hybrid results, the Sec13
binding site on Nup96 was mapped between residues 201-378.
To map the domain of Sec13 that interacts with Nup96, we have expressed
the recombinant WD-repeat region of Sec13 (amino acids 1-302), which is
predicted to form a b-propeller structure (Saxena et al., 1996), and the carboxy
terminal region of Sec13 (amino acids 301-322). Nup96 and the Sec13
binding site of Nup96 interacted with the WD repeat region of Sec13 whereas
the carboxy terminus of Nup96 did not show any significant binding (Fig.
14G). In addition, no significant interaction was observed between full length
Nup96 or Nup96 mutants with the carboxy terminal region of Sec13 (amino
acids 301-322) (Fig. 14G). We have also generated truncated mutants of the
Sec13 propeller region, which disturbed the structure resulting in non-specific
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interactions. Therefore, these mutants could not be used for binding assays
(our own observation). Altogether these results show specific interaction of
the Sec13 propeller domain with an amino terminal region of Nup96.
8.4.2. In Interphase, Sec13 and Nup96 are localized at both Sides
of the NPC in addition to other intracellular Sites
To correlate our genetic and biochemical findings on the Sec13/Nup96
interaction with in situ localization data, we developed an antibody against a
unique carboxyl terminal region of Sec13 (amino acids 244-322). As shown
by immunoblot analysis in Fig. 15A, affinity-purified antibodies raised against
the carboxyl terminal region of Sec13 specifically recognized Sec13 in total
HeLa cell lysates. We then carried out double-immunofluorescence and
confocal microscopy on HeLa cells using these anti-Sec13 antibodies. Sec13
was localized at the endoplasmic reticulum, cytosol, nuclear rim, and at
intranuclear sites (Fig. 15B-D). Sec13 co-localized with Nups that are
recognized by the monoclonal antibody mAb414 (Fig. 15B) and the Sec13-
EGFP fusion protein showed similar localization as the endogenous proteins
(Fig. 15C). In addition, Sec13 partially co-localized with calnexin at the ER
(Fig. 15D). In order to analyze the NPC localization of Sec13 at the
ultrastructural level, we performed double-immunoelectron microscopy in
isolated nuclear envelopes using our newly developed anti-Sec13 antibodies
and the previously characterized anti-RanGAP1 antibodies, which recognize
RanGAP1 at the cytoplasmic side of the NPC (Matunis et al., 1996). As
shown in Fig. 15E, Sec13 was localized at both the cytoplasmic and
nucleoplasmic sides of the NPC as opposed to RanGAP1 that was localized at
the cytoplasmic side of the NPC.
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Figure 15. Immunolocalization of Sec13 to both sides of the NPC in addition to
cytoplasmic and intranuclear sites. (A) Immunoblot analysis of HeLa cell lysates
performed with anti-Sec13 antibodies and probed with either pre-immune serum,
control (lane 1), or with antibodies against Sec13 (lane 2). (B) Immunofluorescence
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and confocal microscopy of HeLa cells, which were fixed, permeabilized with
saponin, and labeled with anti-Sec13 antibodies and mAb414 (labels some FG-repeat
containing Nups). (C) HeLa cells transfected with EGFP-Sec13 and analyzed by
confocal microscopy show similar staining to the observed labeling of endogenous
Sec13 shown in B and D. (D) HeLa cells were processed as in B except that anti-
calnexin antibodies were used instead of mAb414. ER labeling is observed. The
merged image shows partial co-localization of Sec13 with calnexin at the ER. (E)
Isolated rat liver nuclear envelopes were probed with rabbit anti-Sec13 antibodies
and mouse anti-RanGAP1 mAb 19C7. Rabbit and mouse antibodies were detected
with 10 nm and 5 nm gold-coupled secondary antibodies, respectively. Envelopes
were processed for thin sectioning and observed by electron microscopy. C,
cytoplasmic side. N, nucleoplasmic side.
_______________________________________________________________
8.4.3. In Mitosis, Nup98 and Sec13 are diffused throughtout the
Cell whereas a significant Fraction of Nup96 co-localizes with the
Spindle Apparatus
A potential role for Nups in mitosis has been recently reported (Belgareh
et al., 2001). During mitosis, a fraction of Nup133 and Nup107 has been
localized to the kinetochores (Belgareh et al., 2001) raising a potential role for
Nups on kinetochores or as “kinetochore-associated passenger proteins”
which would be involved in the positioning and assembly of NPCs during late
mitotic processes. Nup358 has also been localized at the spindles and
kinetochores (James et al., 1996). Therefore, to determine the localization of
Nup96 and its interacting partners, Nup98 and Sec13, during mitosis, we have
performed double-immunofluorescence and confocal microscopy with anti-
Nup96, anti-Nup98 and anti-Sec13 antibodies in HeLa cells. Both anti-Nup96
(Fig. 16A-C) and anti-Nup96/p87 antibodies (our unpublished observation)
showed co-localization of a major fraction of Nup96 with b-tubulin,
indicating association of Nup96 with the spindle apparatus. Another fraction
of Nup96 localized in a diffuse pattern throughout the cell. In contrast, when
HeLa cells were labeled with anti-Nup98 or anti-Sec13 antibodies and anti-b-
tubulin antibodies, Sec13 and Nup98 did not co-localize with the spindle
apparatus and were distributed in a diffuse pattern throughout the cell
(Fig.16D-I). Thus, Nup96 and Sec13 are distributed differently throughout the
cell during mitosis.
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Figure 16. Nup96 co-localized with the spindle apparatus during mitosis whereas
Sec13 and Nup98 were distributed throughout the cell. Immunofluorescence and
confocal microscopy were performed with HeLa cells at mitosis. Cells were fixed,
permeabilized and labeled with anti-Nup96 and anti-beta-tubulin antibodies (A-C), or
with anti-Sec13 and anti-beta-tubulin antibodies (D-F), or with anti-Nup98 and anti-
beta-tubulin antibodies (G-I). Merged images showed partial co-localization of
Nup96 and beta-tubulin at the spindle apparatus whereas Sec13 and Nup98 did not
co-localize with the spindles and was dispersed throughout the cell.
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8.4.4. Targeting of Sec13 to different Compartments in the Cell
To analyze the mechanism(s) by which Sec13 can be targeted to different
intracellular compartments, fusion proteins containing myc-pyruvate kinase
(PK) fused with full length Sec13 or different regions of Sec13 were
constructed, expressed in HeLa cells and observed in a confocal microscope.
As shown in Fig. 17A, the myc-PK fusion protein, which lacks a NLS, is
known to be localized in the cytoplasm, however, when myc-PK was fused
with full length Sec13, a significant amount of myc-PK-Sec13 was detected in
the nucleus and a smaller pool in the cytoplasm (Fig.17B), indicating that
Sec13 has a NLS and is actively transported into the nucleus. To further
analyze the intranuclear targeting of Sec13, we have fused several different
regions of Sec13 to PK and determined their intracellular localization (Fig.
17C-F and schematics in Fig. 17G). A truncated mutant containing the WD
repeat domain, which is predicted to form a b-propeller structure (amino acids
1-302), targeted PK to the nucleus (Fig. 17F). Further analysis of mutants
showed that the NLS was localized between amino acids 244 and 302 (Fig.
17C-F). This region contains the 6th WD repeat of Sec13. The truncation
mutant of the propeller resulted in incorrect folding of the recombinant
proteins as mentioned in an earlier paragraph in the results section, however it
did not affect the targeting of the PK-fusion proteins. In contrast, the region at
the very carboxy terminus of Sec13 (amino acids 301-322) did not alter the
cytoplasmic localization of PK (Fig.17E). Together, these findings
demonstrate a potential role of specific regions of Sec13 in actively targeting
the full length protein to different intracellular compartments.
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Figure 17. The carboxy terminus of Sec13 contains NLS(s). HeLa cells were
transfected with myc-PK alone (A), or myc-PK fused with full length Sec13 (amino
acids 1-322) (B), or myc-PK fused with Sec13 (amino acids 1-243) (C), or myc-PK
fused with Sec13 (244-322) (D), or myc-PK fused with Sec13 (301-322) (E), or myc-
PK fused with Sec13 (1-302). Transiently expressed proteins were detected by
immunofluorescence and confocal microscopy using anti-myc (9E10) and anti-
Nup358 antibodies, which were labeled with secondary antibodies conjugated with
CY3 and FITC, respectively. (G) The used fusion constructs are schematically
presented and their nuclear targeting is shown.
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8.4.5. Sec13 shuttles between the Nucleus and the Cytoplasm and
stably associates with NPCs
The localization of Sec13 at different intracellular compartments during
interphase lead us to investigate the dynamics of Sec13 in the cytoplasm, ER,
nuclear rim and the nucleus. Full length Sec13 fused with GFP at the carboxy
terminus was transfected into HeLa cells and was submitted to fluorescence
recovery after photobleaching (FRAP) and fluorescence loss in
photobleaching (FLIP) experiments. Sec13-EGFP strongly labeled the ER and
a less intense staining was detected at the nuclear rim, cytoplasm and the
nucleus. The same results were obtained when Sec13 was fused with GFP at
the amino terminus (our own observation). This intracellular localization of
Sec13-EGFP is in agreement with the localization of the endogenous protein
observed in Fig.15 and also with previously published results (Hammond and
Glick, 2000, Tang et al., 1997). To analyze the dynamics of the intranuclear
pool of Sec13, half of the nuclear area of a HeLa cell was photobleached and
recovery of fluorescence was detected after 15s, indicating a very rapid
movement of Sec13 between intranuclear sites (our unpublished
observations). When most of the area of a HeLa cell nucleus was
photobleached, a significant recovery of intranuclear Sec13-EGFP was
detected after 10 min with a halftime of 3.5 min (Fig.18A-B). Altogether,
these results suggest exchange of Sec13-GFP molecules between the nucleus
and other compartments (see Fig. 18 below). Control experiments with EGFP
showed immediate recovery after photobleaching with a half time of
approximately 15 s (Fig.18B).
When FRAP analysis was performed by photobleaching the nuclear
envelope, the recovery of Sec13 at the nuclear rim was still not observed after
45 min, indicating that the pool of Sec13 localized at the nuclear rim is stably
associated with NPCs (Fig. 18C). In this experiment, the selected bleached
area included a region of the NE, part of the ER, cytosol and intranuclear
sites, which was chosen to compare, simultaneously, the dynamics of Sec13 in
these different compartments. As shown in Fig. 18C and as previously
reported (Ward et al., 2001), the pools of Sec13 localized in the cytosol and
ER were recovered very rapidly after photobleaching, indicating rapid
movement of Sec13 between these two compartments. The equatorial section
was chosen since sections closer to the top of the nucleus are in proximity
with the ER where Sec13 is rapidly exchanged, and could then result in
misinterpretations. Interestingly, in FLIP experiments where the ER and
cytosol were photobleached several times (Fig. 19A), a sequential loss of
fluorescence intensity was observed in the nucleoplasm (Fig. 19A-B),
indicating that there is exchange of Sec13 between the ER and cytosol with
the nucleoplasm. Exchange of Sec13 between the ER and cytosol was also
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Figure 18. Dynamics of Sec13 in the nucleus and in the cytoplasm. (A) FRAP
analysis of HeLa cells transfected with Sec13-EGFP. The nucleus was bleached and
the fluorescence recovery in the nucleus was monitored. The image shows a confocal
section at the equatorial plane of the nucleus. Images were acquired every 15 s. (B)
Plots show fluorescence recovery of nuclear Sec13-EGFP in the bleached area.
Measurements of fluorescence intensity were subtracted from background
fluorescence and normalized from loss of fluorescence during bleaching and imaging.
Error bars are standard deviation (n=3 ). (C) FRAP analysis of HeLa cells transfected
with Sec13-EGFP where the NPC, ER and cytosol were bleached and fluorescence
recovery was monitored. Note the instant fluorescence recovery at the ER after 5 min
as opposed to the NPC, which still did not recover after 45 min.
Jost Enninga- Nup98 and Nup96                                                                                     65
observed and occurred almost instantaneously (Fig. 19A). As control for the
FLIP experiments, we have used PML-GFP, that is localized in nuclear bodies
and diffusely in the nucleoplasm, and which has been shown to move inside
the nucleus (Muratani et al., 2002, Wiesmeijer et al., 2002). As shown in Fig.
19B and C, when the cytoplasm of a HeLa cell transfected with PML-GFP
was photobleached several times, the fluorescence intensity of intranuclear
PML-GFP was not reduced, indicating that there is no exchange of PML
between the nucleus and cytoplasm as previously reported (Muratani et al.,
2002, Wiesmeijer et al., 2002). This result also shows specificity of the
findings obtained with Sec13 which, in contrast, is exchanged between the
nucleus and cytoplasm. The FRAP and FLIP experiments with Sec13-GFP
were also performed in the presence of cycloheximide and leptomycin B. No
changes in the results were observed indicating that the intracellular dynamics
of Sec13 is not dependent on ongoing protein synthesis and its nuclear export
is not mediated by the Crm1 pathway. In summary, Sec13 is mobile, shuttles
between the nucleus and the cytoplasm and associates stably with NPCs.
To demonstrate the interaction of Nup96 and Sec13 in vivo and its
potential role in regulating Sec13 dynamics, we have performed FRAP assays
on HeLa cells co-transfected with Sec13-GFP and the Sec13 interacting
region of Nup96 (amino acids 201-427) or with a carboxyl terminal region of
Nup96 (amino acids 428-849) which did not interact with Sec13 (Fig. 20).
Figure 20A shows the recovery curves of fluorescence, and figure 20B shows
the fluorescence after the bleach at a timepoint when no change in
fluorescence intensity could be further detected. Strikingly, the Sec13
interacting domain of Nup96 decreased the number of Sec13-GFP molecules
exchanged between the nucleus and the cytoplasm resulting in an increase of
the immobile pool of Sec13-GFP (Fig.20). This effect was dependent on the
Nup96/Sec13 ratio as indicated in figure 18B. In contrast, the Sec13-GFP
dynamics was not altered in the presence of a carboxyl terminal region of
Nup96 which does not interact with Sec13 (Fig.20). These results
demonstrated a specific interaction of Sec13 with an amino terminal region of
Nup96 in vivo, and a potential role in regulating the intracellular dynamics of
Sec13. These findings also corroborate the interaction of Sec13 with Nup96
shown by yeast two-hybrid and biochemical assays (Fig.14). In summary,
Sec13 is mobile, shuttles between the nucleus and the cytoplasm and
associates stably with NPCs.
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Figure 19. Shuttling of Sec13 between the nucleus and the cytoplasm. (A) FLIP
experiments in HeLa cells transfected with Sec13-EGFP. The bleached region
highlighted includes ER and cytosol. Photobleaching was performed every 4 min and
images were scanned every 30 s. Note the instant recovery of fluorescence at the ER
after bleaching in contrast to the sequential loss of fluorescence observed inside the
nucleus and not at the NPC. Arrows show NPC labeling which is better visualized in
the last panels. (B) Plot of fluorescence loss in the nucleus over time in cells
transfected with Sec13-EGFP, EGFP alone or PML-EGFP. Error bars are standard
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deviation (n=3). (C) FLIP experiments in HeLa cells transfected with PML-EGFP
performed as in (A). Fluorescence loss in the nucleus was not observed after
photobleaching the cytoplasm 10 times.
____________________________________________________________________
Figure 20. Interference of Sec13 dynamics by the Sec13-binding site of Nup96. (A)
Plots show FRAP assays performed with HeLa cells co-transfected with Sec13-GFP
and Nup96 (amino acids 201-427; the Sec13 binding site of Nup96), or Sec13-GFP
and Nup96 (amino acids 428-849; which does not interact with Sec13).
Measurements were performed as in figure 5 (n=6) . (B) Histograms show
measurements by FRAP assays as in A of the total number of mobile Sec13-GFP
molecules in the absence or presence of the Sec13-binding site of Nup96 at ratios of
1:1 or 1:5 or the carboxyl terminal region of Nup96 (amino acids 428-849) at a ratio
of 1:5.
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9. Discussion
9. 1. Overview
All constituents of the yeast and the vertebrate nuclear pore complex
have been identified. However, little is known about their function. Here, we
focused on the characterization and regulation of gene expression of two
major nucleoporins, Nup98 and Nup96.
9.2. The Localization of Nup98 and Nup96 at the Nuclear Pore
Complex
In this study the localization of Nup98 and Nup96 was further
investigated by indirect immunofluorescence and confocal microscopy, and
by immuno electron microscopy. These analyses demonstrated their
localization to both sides of the NPC and additional intranuclear sites (figures
7 and 8).
Previously, several studies have localized Nup98 and Nup96
exclusively at the nucleoplasmic side of the NPC using heparin treated
isolated nuclear envelopes or cryosections of glutaraldehyde fixed dehydrated
mammalian cells (Radu et al., 1995, Fontoura et al., 1999, von Kobbe et al.,
2000, Frosst et al., 2002). Heparin treatment might have resulted in a partial
loss of Nup98 and Nup96 at the NPC indicating that the association of both
Nups with the cytoplasmic side of the NPC was sensitive to heparin, whereas
their association with the nucleoplamic side was resistant. Another
explanation would be that the fixation and dehydration procedure used in the
cryosectioning did not allow epitope exposure.
As mentioned above, the results on Nup98 localization have been
contradictory. First, N-Nup145, the yeast homologue of Nup98, had been
localized to both sides of the NPC with a higher copy number at the
nucleoplasmic side (Rout et al., 2000). Second, it had been proposed that
Nup98 could relocate to the cytoplasm upon inhibition of transcription by
actinomycin D (Zolotukhin et al., 1999). Third, FRAP experiments of GFP
tagged Nup98 indicated shuttling of Nup98 between the nucleus and the
cytoplasm (Griffis et al., 2002). We have performed similar experiments and
have found that the mobility of Nup98 was slower by a factor of 10 than the
values obtained by Griffis and colleagues (our own unpublished observation).
The difference between both approaches was the positioning of GFP in the
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context of the Nup98-fusion protein. Therefore, it is possible that GFP may
affect Nup98 dynamics depending on how its placed in relationship to Nup98.
Thus, the stability of the Nup98 association with the NPC and its dynamics
remain to be investigated.
The localization of Nup98 at both sides of the NPC complicates the
model of protein transport across the NPC which would occur by an affinity
gradient as proposed previously (Ben-Efraim and Gerace, 2001). Nup98 was
assumed to be entirely present at the nucleoplasmic side of the NPC, and it
had the highest affinity to import cargo-receptor complexes. These studies
were performed in vitro, therefore it is not known whether Nup98 could
potentially alter its binding affinities to receptor-cargo complexes depending
on its localization at the NPC. Nup98 has been previously shown to interact
with RCC1 (RanGEF) and, consequently, is a site for GDP/GTP exchange on
Ran and termination of karyopherin b2-mediated nuclear import (Fontoura et
al., 2000). This step would potentially happen at the nucleoplasmic side of the
NPC (Fontoura et al., 2000). It will be interesting to analyze the role of Nup98
at the cytoplasmic side of the NPC where it has been shown to interact with
Nup88 (Griffis et al., 2003).
Nup96 had been shown to be associated with the Nup107-160
subcomplex of the NPC (Fontoura et al., 1999, Vasu et al., 2001), and
members of this subcomplex, such as Nup107, Nup133 and Nup160 were
localized to both sides of the NPC (Belgareh et al., 2001). The symmetrical
localization of the whole Nup107-160 subcomplex at the nucleoplasmic and
cytoplasmic sides of the NPC was also supported by our findings that the
Nup96 interacting protein Sec13 was localized at both sides of the NPC (see
figure 15). Additionally, the yeast homologue of Nup96, C-Nup145p, was also
localized at both sides of the NPC (Rout et al., 2000, Allen et al., 2002a and
2002b). Assuming that heparin treatment may have led to the assymmetrical
localization of Nup96, it can be concluded that at least some interactions of
this complex and/or of Nup96 with the NPC may differ depending on the side
of the NPC it is localized.
Together, our data indicates that Nup98 and Nup96 reside at both sides
of the NPC and that the Nup107-160 and Nup84p complexes are localized at
the cytoplasmic and nucleoplasmic sides of the NPC. Since Nup98 is not a
constituent of any known NPC subcomplex, we speculate that it might carry
out differential functions depending on its localization.
9.3. Nucleoporin Localization and their hypothetical Functions
during Mitosis
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In this study we have shown that, during mitosis, Nup96 was partially
co-localized with the spindle apparatus (Fig. 16), whereas Nup98, which can
interact with Nup96 after cleavage of the Nup98-Nup96 precursor, was
dispersed throughout the cell during mitosis. Furthermore, Sec13, which we
have identified as direct interacting partner of Nup96 in the Nup160-Nup107
subcomplex, was not co-localized at the spindle apparatus during cell division.
The localization of Nup96 with the mitotic spindles suggests a
potential role for Nup96 at this phase of the cell cycle. A role(s) for Nups
during mitosis has been previously proposed based on the association of
Nup107 and Nup133 with kinetochores (Belgareh at al., 2001) and also on the
localization of Nup358 at the kinetochores and spindles (Joseph et al., 2002).
Although the function of these Nups during mitosis have not been elucidated,
it has been proposed that they may constitute an important link between cell
cycle control and NPC assembly and disassembly (Belgareh et al., 2001). This
hypothesis has been strengthened by a recent study which emphasized the
Nup107-160 subcomplex as a keyplayer during NPC assembly after mitosis
(Walther et al., 2003). Another possibility would be that Nups are constituents
and play a role in the kinetochore and/or spindle machinery during mitosis. In
this regard, other components of the nuclear transport machinery, including
Ran, RanGEF, karyopherins a  and b, are known to be key regulators of
spindle assembly (Hetzer et al., 2002, Kunzler et al., 2001).
As mentioned Nup98 and Sec13 did not exhibit significant co-
localization with Nup96 at the spindles during mitosis (figure 16), even
though both are direct interactors. This leads to the speculation whether the
association between these NPC components is dynamic and is cell cycle
dependent. It has been shown that Nup98 is heavily phosporylated by the
mitotic cdc2 kinase in a cell cycle dependent way among several other
components of the NPC (Macaulay et al., 1995, Kehlenbach et al., 2000).
However, no biochemical data has been obtained how the phosphorylation of
Nups affects their mutual binding affinities. In addition pools of Nup98,
Nup96 and Sec13 have been found dispersed throughout the cytoplasm during
mitosis and their association at those sites cannot be excluded. Future research
will address these problems and will also clarify if Nup96 is involved in
tethering other components to the NPC after mitosis.
9.4. The Regulation of Nup98 and Nup96 by Interferons
As described in the previous paragraph, several studies have focused
on the role and regulation of Nups during mitosis and their function during the
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regulated assembly and disassembly of the NPC. Surprisingly, the regulation
of nucleoporins’ gene expression during interphase has not been fully
investigated. We hypothesize here that regulation of nucleoporin gene
expression during interphase plays an important role in adjusting
nucleocytoplasmic transport to varying physiological requirements.
In search for a specific regulator of the Nup98-Nup96 gene expression,
the discovery of Nup96 (Fontoura et al., 1999) suggested the importance of
interferons. As described in the result section of this study, sequence
comparison of the carboxy terminus of Nup96 with a partial clone from an
IFN g induced macrophage subtraction library revealed their identity
(Fontoura et al., 1999, Yang et al., 1995). Therefore, the effects of type I and
type II interferons on the expression of the Nup98/Nup96 gene were tested at
the mRNA and protein levels as depicted in figure 9 and 10. Additionally,
other cytokines were tested for their ability to regulate the Nup98-Nup96 gene
expression to investigate the specificity of regulators and the involved
signaling pathways. As interferon signals are mediated mainly by the
JAK/STAT pathway and partly by the MAP-kinase signaling, TNFa, which
does not activate JAKs and STATs, was an ideal candidate to distinguish
between both pathways. Furthermore, STAT1 knock out cell lines were used
to investigate the importance of this molecule in regulating Nup98 and Nup96.
Nup98 and Nup96 were induced upon IFN g and IFN a treatment at
the mRNA level (figure 9 A and data not shown) and at the protein level
(figure 9 B and 10). Interferon stimulation also induced alternative splicing
(figure 8 C and 9 A) of Nup96 resulting in the expression of p87 (figure 9 A).
The alternative splicing event was dependent on the induction of other
proteins by interferons because treatment with cycloheximide prevented it to
occur. In contrast, TNFa, which signals through the MAP-kinase pathway and
not through the JAK/STAT pathway, had no effect on Nup96 and p87 gene
expression confirming the importance of the JAK/STAT (figure 9). These
findings were complemented using STAT1 deficient cell lines, which did not
show any regulation of the Nup98 and Nup96 proteins upon interferon
stimulation (figure 10). Finally, we were able to demonstrate that Nup98 and
Nup96 protein amounts are increased at the nuclear envelope and at
intranuclear sides. However, no shift in localization was observed (Fig. 11).
We hypothesize that the number of NPCs does not change upon interferon
stimulation because the protein levels of other Nups were not affected, and the
cellular morphology was not altered. Thus, the newly synthesized Nup98 and
Nup96 are localized at additional NPC and intranuclear sites.
Interferons mediate mainly growth inhibition and antiviral response
(Boehm et al., 1997, Stark et al., 1998). Since a functioning nuclear pore
complex is necessary for cell vitality and since many viral particles have to be
shuttled between the nucleus and the cytoplasm, regulation of the constituents
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of the NPC could be a major mechanism in the antiviral response as discussed
in the next section.
9.5. Potential Roles of Nup Regulation by Interferons in antiviral
Responses
In figure 13 we revealed that induction by interferon g  or
overexpression of exogenous Nup98/Nup96 reverted a block in mRNA export
mediated by the vesicular stomatitis virus M protein.
The mechanism by which increased expression of Nup98 and of
Nup96 reverses M protein-mediated inhibition of mRNA export remains to be
elucidated. The inhibitory region of the M protein has been mapped (von
Kobbe et al., 2000, Petersen et al., 2000) and shown to target the NH2-
terminal domain of Nup98 (residues 66-515) (von Kobbe et al., 2000). The
co-localization of M protein with Nup98 is also illustrated in figure 12. Nup98
(residues 66-515) contains several distinct domains including FG repeats that
function as docking sites for karyopherins (also termed importins, exportins or
transportins) and a binding site for RanGEF that catalyzes the exchange of
GDP for GTP (Fontoura et al., 2000). It is conceivable that the M protein
interferes with the function of any of these Nup98 domains resulting in the
observed RNA export defects. Over-expression of Nup98 could then
compensate for the loss of these functions, thereby reversing the inhibition of
RNA export.
Another example for virus interference with nuclear transport at the
level of nucleoporins is the polio and rhino virus-induced degradation of two
specific Nups (Nup153 and p62), which leads to protein import defects
(Gustin and Sarnow, 2001 and 2002). Besides playing a key role in antiviral
responses, the up-regulation of Nup98 and Nup96 may be involved in other
processes mediated by IFN, such as innate immunity and cell proliferation.
Nup98 is a frequent target of chromosomal rearrangements in acute leukemia
(Ahuja et al., 2001, Lam and Aplan, 2001). Its NH2-terminal FG repeat region
is present in all leukemia-associated Nup98 fusions that cause chronic and
acute myeloid leukemias (Kroon et al., 2001). Nup98 and Nup96 may thus
play a role in a broad range of activities that can be potentially regulated by
different signaling pathways.
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9.6. Searching for Nup96 Interactors: Sec13- a Protein which is
localized at the NPC and shuttles between the Nucleus and the
Cytoplasm
We have identified Sec13 as a Nup96-interacting partner during
interphase, when both proteins co-localized at the nucleoplasmic and
cytoplasmic sides of the nuclear pore complex. To investigate Nup96-
interacting partners, we have performed yeast two-hybrid screenings using
three different libraries including, B-cells, breast and placenta. Strikingly, we
pulled out Sec13 in all screenings (Fig.14 A-C). In addition, we have
confirmed this interaction by in vitro binding assays and we mapped the
Sec13 binding site to its the propeller repeat containing N–terminus with the
amino terminal region of Nup96 (amino acids 201-378) (Fig.14 D-G). The N
terminal region of Nup96 is also present in another isoform of the same gene
denominated p87, whose function is not known and which is only expressed
in very low amounts under specific conditions such as interferon treatment.
The interaction of Nup96 with Sec13 is corroborated by previous findings
where a complex of mammalian nucleoporins which contains Nup96,
Nup107, Sec13, at least one Sec13-related protein, and at least two additional
proteins of ~150 kD has been identified (Fontoura et al., 1999). Also in
agreement with these results, studies using Xenopus egg extracts have found
Sec13 in a complex containing several Nups including Nup160, Nup133,
Nup107 Nup96, and Nup85, although the Sec13 direct interacting partner was
not determined (Belgareh et al., 2001, Vasu et al., 2001; Harel et al., 2003). In
yeast, Sec13 was shown to be a constituent of the scNup84 complex, which is
homologous to the Nup107-160 complex in vertebrates (Lutzmann et al.,
2002, Siniossoglou et al., 1995 and 2000). Furthermore, interaction of C-
Nup145p, the yeast homologue of Nup96, with Sec13 has been demonstrated
to be an integral part of a Y-shaped multiprotein complex, Nup84p complex,
constituted of seven nucleoporins which have been recently assembled in vitro
(Lutzmann et al., 2002, Siniossoglou et al., 2000). In conclusion, Sec13
interacts with Nup96 and they are both constituents of a highly conserved
NPC subcomplex
These findings on the interaction of Sec13 with Nup96 support our results
on the sub-localization of Sec13 and Nup96 to both sides of the NPC (Fig. 8 E
and 15 D). To perform the indirect immuno fluorescence and the immuno
electron microscopy studies, we have developed a new antibody against a
carboxy terminal region unique to the Sec13 protein. Indirect immuno
fluorescence revealed that Sec13 is localized at the NPC in addition to its
localization at the ER and intranuclear sites. Immuno EM demonstrated
localization of Sec13 on both sides of the NPC.
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Our findings on the sublocalization of Sec13 at both sides of the NPC
are corroborated by the studies of Belgareh et al which showed that Nup107
and Nup133- in the same subcomplex as Sec13- are localized at both the
cytoplasmic and nucleoplasmic sides of the NPC (Belgareh et al., 2001).
Thus, these studies indicate that the Nup107-160 and Nup84p complexes are
localized at the cytoplasmic and nucleoplasmic sides of the NPC.
9.7. Two separate Pools of Sec13 reveal structural and functional
Differences
In addition to its localization at the NPC, Sec13 is also localized at the
ER, cytosol, and at intranuclear sites (Fig. 15). Although a small intranuclear
pool of Sec13 has been previously observed, it has not been studied (Tang et
al., 1997, Hammond and Glick, 2000). By using our newly developed
antibody against the carboxy terminal region of Sec13, we have clearly
demonstrated that a major pool of Sec13 is also present in the nucleus (Fig.15
B), which has not been fully demonstrated previously probably due to
differences in epitope exposure. Furthermore, Sec13-GFP also localized at
intranuclear sites in addition to the NPC and cytoplasm (Fig. 15), and full
length Sec13 was able to target a cytoplasmic protein, pyruvate kinase, into
the nucleus (Fig.17). In the cytosol, Sec13p interacts with Sec31p, and
together with Sar1p and the Sec23p-Sec24p complex, they are recruited to the
ER membrane for biogenesis of the COPII coat complex (Kaiser and Ferro-
Novick, 1998). This complex is known to mediate vesicle budding from the
ER (Kaiser and Ferro-Novick, 1998). Thus, Sec13 is part of at least two
distinct multiprotein complexes localized at the NPC and ER. The presence of
WD repeats on Sec13, which are usually involved in protein-protein
interactions within macromolecular complexes (Smith et al., 1999), is
consistent with Sec13 being a constituent of both NPC and COPII
multiprotein complexes. It is possible that different WD repeats are involved
in the interaction of Nup96 at the NPC and with Sec31 in the cytoplasm. The
localization of Sec13 at multiple intracellular sites led us to investigate the
intracellular dynamics of Sec13. Photobleaching experiments performed with
Sec13-GFP showed that there is a pool of Sec13 that is stably associated with
NPCs whereas the cytoplasmic and intranuclear pools are very dynamic and
Sec13 is exchanged between the nucleus and the ER and cytosol (Fig. 18 and
19). The stable association of Sec13 with the NPC is compatible with a
putative structural role in the Y-shaped NPC subcomplex and also is in
agreement with the stable association of Nup133 and Nup107 with the NPC
(Belgareh et al., 2001), which are constituents of the same subcomplex. In
contrast, the pool localized at the ER was rapidly exchanged with the
cytosolic pool (Fig. 18 C) Strikingly, when the Sec13 binding site of Nup96
was co-transfected with Sec13-GFP, the mobile pool of Sec13 was reduced
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demonstrating in vivo the interaction of Sec13 with the Sec13 binding site of
Nup96 and its potential role in regulating Sec13 dynamics (Fig. 20) (Ward et
al., 2001).
Interestingly, it has been reported that the arrest of secretion response
(ASR) in some sec mutants inhibits nuclear import and relocate nuclear
proteins and Nups to the cytoplasm as a potential mechanism for “biosynthetic
economy” which allows the cell to handle the secretion defect (Nanduri and
Tartakoff, 2001). These findings established a crosstalk between the ER, NPC
and the nucleus. Although Sec13 was not shown to be part of this specific
pathway, it could potentially be a constituent of similar mechanisms of other
stress responses, which would be involved in coupling nuclear and
cytoplasmic functions. Consistent with this mechanism, it has been recently
shown that mutant alleles of all COPII constituents, including Sec13, affected
Nup localization (Ryan and Wente, 2002). In these studies it was proposed
that blockage of the secretory pathway could titrate away the pool of Sec13
that is associated with the NPC or that the abnormalities of the NE found in
these mutants could prevent NPC assembly (Ryan and Wente, 2002).
We have also shown that the targeting of Sec13 to the nucleus or
cytoplasm may be regulated by specific regions of the Sec13 protein. Whereas
the 6th WD repeat region contains NLS(s), other regions of Sec13 may retain
it in the cytoplasm or contain NES(s) (Fig. 17). Thus, it would be important to
dissect the molecular mechanisms that couple the ER with the NPC and
nucleus.
9.8. Conclusion
Here we used different approaches to characterize two major
nucleoporins termed Nup98 and Nup96. We were able to localize these Nups
to both sides of the NPC. Furthermore, we found that these Nups are involved
in a novel antiviral response mechanism which reverses a mRNA export block
mediated by the vesicular stomatitis virus M protein. Searching for interacting
partners of Nup98 and Nup96, we found that the propeller repeat region of
Sec13 binds to the N terminus of Nup96, and that Sec13 shuttles between the
nucleus and the cytoplasm.
The NPC has been previously considered a static structure, which
mediates all nucleocytoplasmic exchange. By using the approaches described
above, we were able to look at the NPC in a more dynamic way: First, a
specific subset of Nups was found to be specifically regulated by interferons.
Secondly, the NPC constituent Sec13 shuttles between different cellular
compartments. These findings demonstrate that the paradigm of the NPC as a
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“fixed” structural entity has been changed. Possibly, some Nups carry out
singularly structural functions. However, most Nups have additional roles in
the cell. It will be interesting to investigate the dynamic properties of other
Nups considering their function in nucleocytoplasmic transport. These studies
will potentially lead to a new concept of the NPC, which will define it as a
highly regulated structure being adaptable to different physiological
environments.
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